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Conjugative transposons are mobile genetic elements capable of intercellular
transfer [1]. Apart from many similarities to conventional transposons, the mechanics of
transfer of these elements resemble those of E. coli conjugative elements. As these
elements are capable of conjugative transposition to various species of bacteria, they have
been cited as the chief reason for emergence of multiple antibiotic resistance in Gram
positive pathogens [2].
For several years, the research efforts in our lab have been focused on the biology
of the streptococcal conjugative transposon, Tn5252, originally identified as a
chromosome-borne element in Streptococcus pneumoniae. The left and right terminal
regions have been characterized based on genetic, structural, and functional analyses of
the DNA sequence. Several transfer-related genes were identified. These include a site-
specific recombinase, excisionase, relaxase, a regulator of conjugative transfer, and
several genes that are predicted to be involved in DNA transport. Interestingly, all these
genes are clustered in the terminal regions of the element [3-8].
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Compared to the left and right terminal regions, not much is known about the
central 25 kb of Tn5252 except that no apparent transfer-related genes are present in this
region. Though the sequence of the central region of Tn5252 has not been determined
completely, we do have partial sequence data, at least one strand DNA sequence of this
region. Recently, the genomic DNA sequence of clinical strain of Streptococcus
pneumoniae, G54, was published [9]. A Tn5252-like element was identified in the
genomic sequence. In the central region of this element, there exists a big operon, which
shows significant similarity to our partial sequence data. All of these seem to imply that
the big operon also exists in our transposon. In the operon in G54, there are 4 open
reading frames. ORF2, the major part of the operon, encodes a large protein of 2074
amino acids, containing methylase and helicase domains. A blast search using the amino
acid sequence of ORF2 also showed similar proteins with significant similarity not only
in other species of Streptococcus, but also in Enterococcus, Bacteroides, Vibrio,
Clostridium and so on. However the exact function of this protein is not known.
Specific aims proposed:
1. To carry out virulence assays to determine if the operon in the
central region of Tn5252 is related to the virulence of pneumococcus.
2. To determine whether this operon is inducible or constitutive by
constructing a transcriptional fusion with the E. coli lacZ gene.
3. If this operon is related to the virulence of pneumococcus,




Streptococcus pneumoniae (pneumococcus) belongs to the family
Streptococcaceae and is a Gram positive α-hemolytic bacterium. Normally it is a
commensal resident in the upper respiratory tract of 5-10 % of healthy adults and 20-40%
of healthy children [10]. However, it can invade and cause minor to life-threatening
diseases. In the United States of America, pneumococcus was annually responsible for
about 50,000 cases of pneumonia, 3000 cases of meningitis and 7 million cases of otitis
media annually before the introduction of the conjugate vaccine. Introduction of the
conjugate vaccine has successfully decreased the rate of invasive disease from 21-33
cases to 13 cases per 100,000 in the population [11]. However, eradication of the diseases
caused by pneumococcus is still far from expectations. Today, people at extreme ages
and/or with a compromised immune systems are still at a much higher risk of invasive
infection by pneumococci [12].
Pathogenesis of S. pneumoniae
Due to its significance in terms of its morbidity and mortality, pneumococcus has
attracted significant research interest. In the past 100 years, there has been a lot of
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improvement in the identification and characterization of pneumococcal virulence
factors and virulence genes. However, the detailed mechanism of pathogenesis is still not
fully elucidated. In the following narrative, most of the factors that are currently known
to contribute to the survival of pneumococcus during invasion and infection will be
reviewed.
Pyruvate oxidase
S. pneumoniae is a fermentative aerotolerant anaerobe. It has the common
glycolysis pathway to break down carbohydrates ultimately to pyruvate. However, the
tricarboxylic acid (TCA) cycle and electron transport chain are missing [10]. As shown in
Fig 1, in anaerobic growth conditions, pyruvate is further degraded to lactate or formate
[13]. Though pneumococcus prefers an anaerobic environment, it is able to survive and
grow in an aerobic environment. In the presence of oxygen, pyruvate oxidase can
catalyze the reaction to convert pyruvate to generate acetyl-P using oxygen [14]. Acetyl-
P is involved in a further reaction to generate ATP[15]. This reaction is not only a
method to degrade pyruvate and promote glycolysis, but more importantly, it is a reaction
to detoxify oxygen and generate hydrogen peroxide, which is taken advantage of by
pneumococcus to compete and inhibit other potential pathogens residing in the
nasopharyngeal region [16]. A number of studies have shown that pyruvate oxidase is
required for both nasopharyngeal and intraperitoneal infection. In particular, clinical
strains carrying a mutation in pyruvate oxidase were found to be deficient in their
capacity to attach to
5
Fig 1. Central metabolism pathway in S. pneumoniae. In aerobic environment, pyruvate
is degraded by a reaction catalyzed by pyruvate oxidase. In an anaerobic environment,
pyruvate degraded by a reaction catalyzed by lactate dehydrogenase or pyruvate formate
lyase [14].
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vascular endothelial cells and type II lung cells [14]. However, a detailed understanding
of the role of pyruvate oxidase in pneumococcal pathogenesis is not yet available.
Capsule
The capsule of pneumococcus has been identified as a virulence factor for a long
time. It is a thick polysaccharide layer residing outside of the pneumococcus cell-wall
[17]. The lethal dose for encapsulated strains is only 50% of the non-encapsulated strains.
Consistently, encapsulated strains are found to be about 105 more virulent than non-
encapsulated strains [18]. So far, more than 90 different serotypes of capsule have been
identified and there is no cross immune-reactivity between them [19]. Through blocking
the access of cell wall localization by the complement system, the capsule ultimately
blocks phagocytosis [20-22]. Different degrees of virulence have been observed with the
various types of capsules. However, it has been shown that the capsule is not the sole
determinant of pneumococcal virulence. The genetic background is also very important
for the full expression of virulence, indicating that other possible factors are involved in
pathogenesis [23].
Pneumolysin
A potent cytolysin, termed pneumolysin, has been observed to be present in every
clinical isolate of pneumococcus. It is a cytoplasmic protein which is not automatically
secreted outside after synthesized. The cytotoxic function of pneumolysin on host cells
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thus is directly dependent on an another pneumococcal virulence factor, autolysin [22,
24]. Once pneumolysin has accumulated in high concentration, it oligomerises to form
pores on mammalian cell membranes and causes cell lysis. Due to the action of the
pneumolysin, ciliated bronchial epithelial cells are damaged and lose their normal
function to clear mucus from the lower respiratory tract, which ultimately facilitates the
spread of pneumococcal infections. Pneumolysin is also able to cause damage to alveolar
epithelial cells, which enriches infected cells with nutrients from alveolar flooding. More
importantly, disruption of the alveolar-capillary boundary facilitates penetration of
pneumococcus through the epithelium and ultimately enterance into the blood stream
[25-27]. At low concentrations, pneumolysin can still inhibit neutrophil and monocyte
respiratory bursts, chemotaxis, production of lymphokines, and immunoglobulins [28].
Autolysin
Autolysin belongs to a large group of enzymes which have the ability to degrade
the peptidoglycan backbone of bacterium. The regulated action of autolysin does not
necessarily lead to complete lysis of a bacterial cell. Mostly autolysins are involved in
bacterial cell wall synthesis, its turnover, and separation of cells during division [29].
Under laboratory conditions, autolysin, (encoded by lytA), is responsible for autolysis
during stationary phase and competence development. As mentioned above, autolysis of
pneumococcal cells during infection helps to release pneumolysin. Also, it has been
reported that a host defense factor, lysozyme, can trigger the release of autolysin, and
ultimately, help to release Pneumolysin [22, 30].
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Pneumococcal surface protein A (PspA)
PspA is located on the cell wall of pneumococcus. It displays structural and
antigenic variability among different pneumococcal strains. During infection, PspA helps
to inhibit complement activation to facilitate pneumococcal infection [22].
Pneumococcal surface antigen A (PsaA)
PsaA is a membrane protein, composed of 309 amino acids with a molecular
weight of 34, 539 Da[22]. A psaA- mutant has been shown to be avirulent in both
intraperitoneal and intranasal challenges model [31]. PsaA protein belongs to the ABC-
transporter family with an ATP binding subunit. Sequence analysis suggests that it is
responsible for the transfer of Zn2+ and Mn2+ from outside into the cytoplasm of a
pneumococcal cell. Failure to acquire Zn2+ and Mn2+ during infection might be the real
reason that psaA- mutants become avirulent in intraperitonial and intranasal challenges.
Consistent with this observation, it has been shown that Mn2+ is not only required by
superoxide dismutases (SOD) of pneumococcus to detoxify hydrogen peroxide generated
during aerobic growth, it also serves as a signal which is required for the induction of
several virulence related genes in pneumococcus within different host sites [32, 33]. The
function of Zn2+ during pneumococcal infection is not very clear. It has been shown that
zinc deficiency in the diet of mice will lead to low concentrations of Zn2+ in both femur
and plasma. Ultimately the mice showed reduced immune response to PsaA antigen,
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suggesting more extensive pneumococcal colonization and severe infection with an
increased risk of death [34].
Hyaluronate lyase
Hyaluronate lyase, a surface protein of pneumococcus, belongs to a broader group
of enzymes, named hyaluronidases. It is required for full virulence of pneumococcus.
During infection, it is responsible for breaking down extracellular matrix components to
increase tissue permeability. Mostly it is associated with pneumonia, bacteremia, and
meningitis [22, 24, 35].
BgaA
In most other bacteria, β-galactosidase (BgaA) is the key enzyme responsible for
lactose metabolism. However, in pneumococcus it is not involved in lactose utilization,
since bgaA- mutants can still use lactose as the only carbon source [36]. Recently it was
reported that BgaA, together with NanA and StrH, two exoglycosidases, contributes to
attachment on the cell surfaces and initiation of colonization through cleavage of
mammalian glycol-protein [37]. Expression of BgaA is induced by lactose, the biological
significance of which is not clear yet.
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Zinc metalloproteinase (Zmp)
According to the published genomic sequences of three pneumococcal strains,
(R6, TIGR, and G54), at least two different kinds of zinc metalloproteinases are present
in all strains. Strain R6 process ZmpA, an IgA-specific proteinase. It cleaves the hinge
region of IgA, helping pneumococcus survive in the nasopharyngeal region. ZmpB, a
virulence factor involved in both intraperitoneal and intranasal infection, can promote
TNFα production in the host [38]. Besides these two zinc metalloproteinases in the R6
strain, the TIGR strain also carries ZmpC, a matrix metalloproteinase, which is involved
in matrix remodeling during infection. Its effect in virulence is not as important as ZmpA
and ZmpB. Besides the above three, in G54, there exists another zinc metalloproteinase,
ZmpD, which is also involved in virulence. Its function and biological significance still
remain to be determined [39, 40].
Two component signal transduction system
Two component signal transduction-systems (TCS) are employed by bacteria to
sense various signals in the outside environment to adjust and regulate cellular processes
accordingly. They are mostly composed of a membrane-associated sensor histidine
kinase (HK) and a cytoplasmic congnate response regulator (RR). An external stimulus
will activate HK and make it autophosphorylate itself. Then the phosphorylated HK will
further phosphorylate RR. RR, mostly a DNA-binding transcriptional regulator, assumes
a conformational change following phosphorylation, and as a result, a given set of genes
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may be up-regulated or down-regulated. So far, 14 TCSs have been identified in
pneumococcus, eleven of which have been shown to have roles in virulence [41]. Some
of them, such as TCS04, have been shown to directly regulate already known virulence
factors, while most of them are involved in complex regulatory networks [42]. The
details of these global regulatory networks are yet to be determined.
Phase variation in pneumococcus
As has been mentioned, pneumococcus is able to colonize different niches with
different ecological characteristics within the human host. The nasopharyngeal region is
an aerobic environment, while most of the other places provide anaerobic environments.
Pneumococcus has developed a mechanism involving phase variation to adapt to these
different environments. Phase variation in pneumococcus has been correlated with
variations in colony morphology: transparent and opaque [43]. Each phase has a different
profile of gene expression inside the cell. Under laboratory conditions, a clinical isolate
can spontaneously change its colony morphology at a frequency ranging from 10-5 to10-7.
Infection experiments have shown that transparent variants are able to attach to human
vascular endothelial cells and cytokine-stimulated type II lung cells with high efficiency
[43]. As a result, they are able to establish into more dense and stable colonies on
mucosal surfaces of the nasopharynx. They also efficiently bind to platelet-activating
factor receptor which allows the bacterial cell cross these cells and the blood-brain barrier
more efficiently [44]. On the other hand, opaque variants are able to more efficiently
cause systematic infections after intraperitoneal inoculation into mice[45]. It is suggested
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that such increased virulence is due to decreased opsonophagocytic killing of opaque
pneumococci [46]. This has been shown by in vitro experiments. By comparing the
expression profiles of transparent and opaque variants, it has been determined that
expression of pyruvate oxidase and a putative proteinase maturation protein homolog are
increased while expression of a putative elongation factor, Ts, is decreased [47].
However, the detailed mechanism of how phase variation happens during infection and
how it is regulated are not fully understood.
Treatment of infections due to pneumococcus
The conjugate vaccine based on pneumococcal capsular polysaccharide serotypes,
is still not as successful as expected. Many groups of individuals have a poor immune
response to one or more than one kind of capsular polysaccharide in the vaccine,
especially people of extreme ages [48, 49]. Conjugative vaccines, in which smaller
numbers of polysaccharides are chemically conjugated to non-pneumococcal proteins,
have improved the immunogenity of the polysaccharides. However, the conjugative
vaccine still has only a limited effect, since pneumococcus periodically goes through
modifications of the capsule. Moreover, the high costs involved in making the vaccine
are still a factor limiting its widespread use [24, 50].
Antibiotics are still the best way to treat the diseases caused by pneumococcus.
With indiscriminate use of antibiotics in some communities, pneumococcus has gradually
gained resistance. In the 1960s, almost all clinical isolates of pneumococcus were
13
sensitive to β-lactam antibiotics. Currently, β-lactam resistance in pneumococcus is quite
common. In 2000, more than 15 % of clinical isolate show complete resistance to
penicillin. Some strains of β-lactam resistance pneumococcus also show resistance to
multiple antibiotics such as erythromycin, macrolides, and clindamycin. These factors
underscore the need and urgency for an enlarged understanding of the biology of this
human pathogen [51-54].
Conjugative Transposon
Conjugative transposons are responsible for the dissemination of multiple
antibiotic resistance among pneumococci
Emergence of multiple antibiotic resistances in pneumococcus was initially
thought to be associated with plasmids. However the efforts to identify the related
plasmids were not successful [55-58]. Though pneumococcus is able to accept and
maintain plasmids from other streptococci, no plasmids have been discovered in most of
the clinical isolates. On the other hand, Shoemaker et al. [59] showed that antibiotic
resistance determinants were part of a chromosome-borne genetic element. This element
was able to transfer within the same and between different species of streptococci by a
process requiring direct cell-to-cell surface contact. Since the whole process was resistant
to DNase, the possibility of transformation was eliminated. This large fragment of mobile
DNA was named a conjugative transposon.
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Conjugative transposons which are quite different from most common
transposons have a completely different mechanism of transposition. It is named
“conjugative” because the transferred molecule originates in a different cell from the
recipient. Cell-to-cell direct surface contact is required for the initiation of transposition
[2]. The transposon then excises itself out of the chromosome to form a circular
intermediate. With the help of a DNA relaxase, one strand is relaxed from the circular
intermediate and further transferred into recipient cells through a mating structure formed
by the conjugative transposon. In the recipient cells, the newly received DNA
recircularize before it integrates into the chromosome in a reaction requiring the activity
of the integrase encoded by transposon [1].
Classification of Conjugative Transposons
DTnERL/CTnDOT family of conjugative transposons in Bacteroides
Conjugative transposons identified in Bacteroides vary in size from 45 kb to 150
kb[60]. There are 5 to 8 preferred sites in the Bacteroides chromosome at which
conjugative transposons insert. Most transposons identified in Bacteroides fall into two
groups: DTnERL and CTnDOT, both of which have the same regulatory backbone
except that CTnDOT contains an extra 13 kb DNA which renders resistance to the
macrolide-lincosamide-streptogramin group of antibiotics [61]. All transposons
belonging to this group share a conserved sequence at the and right ends while the
sequence in the center varies. The presence of subinhibitory concentrations of
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tetracycline can induce excision of the transposon 100~1000 times more frequently and,
in this case, self-transfer of the transposon to other loci in the chromosome results in the
absence of any mating partners [62].
When the conjugative transposon transposes, three other kinds of elements can be
co-transferred at the same time. First, a conjugative plasmid in the donor cells is able take
advantage of the mating pore formed by conjugative transposon during transfer. In this
case, conjugative plasmid will use its own machinery to nick at its own oriT and initiate
conjugative transfer[62]. Second, the non-replicating Bacteroides unit (NUB) can also be
co-transferred during conjugative transfer. In comparison to DTnERL/CTnDOT, NUBs
are smaller in size. Sequence alignment shows that NUB has a significant similarity to
DTnERL/CTnDOT except that they do not possess the regulatory genes required for
transfer related genes. When DTnERL/CTnDOT gets activated for transfer, NUB can
take advantage of the integrase and excisionase encoded by DTnERL/CTnDOT to excise
out of the chromosome and form a circular intermediate. The NUB then uses its own
protein, mob, to nick at oriT that relaxes one strand out. The same as DTnERL/CTnDOT,
NUB need the mating pore formed by conjugative transposon to transfer the relaxed
strand into the recipient cells [63]. Third, the mobilizable transposon Tn4399 can also be
co-transferred along with DTnERL/CTnDOT. Tn4399 transfers by the same mechanism
as NUB, in a way that Tn4399 requires the integrase and excisionase system and mating
pore system of the conjugative transposon for its own transfer. However, the detailed
mechanism is not clear yet. There are two genes, mocA and mocB, in Tn4399 that are
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required for mobilization of Tn4399, but no circular intermediate has been identified so
far [64].
Conjugative Transposons in Enterobateriaceae
So far, there are three groups of conjugative transposons identified in
Enterobacteraceae. They are R391, belonging to incompatibility J group (IncJ), isolated
from Proteus rettgeri [65]; CTnscr94 isolated from Salmonella senftenberg [66]; and the
SXT element isolated from Vibrio cholera 0139 [67]. All of these three elements contain
the λ-type integrase system. Though there is evidence of independent conjugative transfer
in each element, the detailed mechanisms are yet to be determined. Study of
pathogenicity islands shows that enteric pathogenicity islands have similar regulatory
backbone structures similar to these conjugative transposons[68].
Tn916: A Model to Study Mechanism of Transposition
Tn916 was originally discovered in the hemolytic multidrug-resistant E. faecalis
DS16 [69]. It is an 18 kb element carrying tetM, which renders the host tetracycline
resistance. An interesting feature of this element is that the presence of subinhibitory
concentrations of tetracycline can increase the conjugation efficiency more than 1000-
fold [70]. It was discovered that a number of conjugative transposons from various
sources also possess tetM and similar regulatory genes, which implies a similar
mechanism of transposition shared by these elements. For this reason, Tn916 has been
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used as a model to study the regulation of transposition. All the genes required for
integration, exicision and regulation of integration and excision are located near the
junctions. Integrase is responsible for the excision of the transposon from the
chromosome in the donor and site-specifically inserts the element transposon into the
chromosome of the recipient [70]. Complementation experiments showed that an active
int gene in the donor cell was sufficient for the whole process of conjugal transfer,
implying that the integrase function in the recipient was actually provided by the donor
cells[71]. The gene encoding Xis is located directly upstream of int and is required for
excision to form circularization of the element in the donor. It can bind to both junctions
of the transposon, with higher affinity for the left junction and lower affinity for the right
junction. When there is a just sufficient amount of excisionase, it prefers to bind to the
left junction which stimulates the excision function. When there is an excess, excisionase
begins to bind to the right junction which represses excision [72, 73]. Different from that
of E.coli λ phage in which an integration host factor (IHF) plays an important role in
facilitating integration and excision, the IHF has very little effect on excision and
integration of Tn916. It has been reported from different sources that excision of Tn916
happens more than 1000-fold in E.coli in comparison to a Gram-positive host. Originally
this was explained by expression of int and xis in Tn916 being loosely regulated in E.coli.
However, over expression of int and xis did not increase excision of Tn916 to the
expected level in a gram positive organism. Recently it was explained that, in E. coli,
histone-like factor (HU) greatly enhances excision probably by enhancing the integrase-
excisionase-DNA structure formed during excision [73].
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Tn5252
Conjugative transposon Tn5253 was originally discovered in a clinical isolate of
S. pneumoniae, BM6001. It was shown to be a composite structure of two independent
conjugative transposons, Tn5251 which showed extensive similarity to Tn916, and
Tn5252, a unique type of element. Tn5252 recognizes a specific att site of 35 bases for
genetic integration. After insertion, the att site is duplicated and flanks the transposon as
direct repeats [4].
Transfer-related Genes in Tn5252
By DNA sequencing, genetics and biochemical analyses, most of the transfer
related genes of Tn5252 were shown to be located in the two termini of the transposon.
Similar to the structure of transposon Tn916, at the left end there are int and xis which are
responsible for integration and excision of transposon during conjugal transfer [4]. In the
left end, there is another operon with three open reading frames, orf4, orf9 and orf10.
Though the exact functions of orf9 and orf10 are not known, orf4 has been found to
encode a protein with a DNA relaxation function. It is thought to bind to the oriT in the
circular form of transposon and to make a nick during transposition[6]. Also on the left
side, there is orf3 which encodes a protein with putative regulatory function. An insertion
mutation in orf3 completely abolishes conjugal transfer during mating. On the other hand,
in the mutant strain the function of orf3 cannot be complemented in trans by providing a
plasmid carrying the intact orf3 [7]. On the right junction, an operon with several open
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reading frames is present. The deduced amino acid sequence of these open reading
frames show high similarity to membrane mating components formed by conjugative
plasmids during conjugation, which implies that these open reading frames probably
encode the protein products for channel formation required for conjugative transposition
of the element [8].
Non-transfer Related Genes in Tn5252
At the right junction, there is a gene encoding cytosine methylase that is
constitutively expressed. Insertion mutations within this gene do not have detectable
influence on conjugal transposition [74]. The biological significance of this gene is still
not known. In the central region of the transposon next to relaxase operon, there is an
operon with four open reading frames. The deduced amino acid sequence of one of these
shows high similarity to the umu protein which is responsible for DNA damage repair in
the SOS system. It has also been shown that this operon gives the bacterium resistance to
higher doses of UV light [75].
Also in the central region of the transposon, there is a cat gene which is able to
give pneumococcus resistance to chloramphenicol. It has been shown that the cat gene in
Tn5252 is flanked by an IS-like sequence. Spontaneous recombination between the IS-
like sequences flanking the cat gene would make the host cell lose resistance to
chloramphenicol by the “curing” of this segment of DNA. This instability of cat in
Tn5252 implies that the significance of Tn5252 to pneumococcus might not be to provide
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chloramphenicol resistance, as traditionally suggested. On the other hand, determinants
of the actual advantage rendered by Tn5252 rely on further analysis on the non-transfer
related genes in central region. In the work presented following, we studied the function
of an operon with 4 open reading frames, the majority part of which encode a DEAD-box
protein with 2074 amino acids having a molecular weight of 239.8 KDa. Virulence
assays indicate that this operon is able to modulate the virulence of pneumococcus
depending on the route of infection. Following that, we carried out efforts to determine





All the non-encapsulated avirulent S. pneumoniae strains used in this study were
derived from the non-encapsulated wild type strain, Rx1 [76]. The detailed genotype of
each strain is listed in Table I. All the E. coli strains used in this study are listed in Table
I. 
 
Growth and Storage of Bacterial Strains
Medium for S. pneumoniae
Casein hydrolysate (CAT) medium was used to grow all pneumococcal strains
unless mentioned otherwise. The CAT medium was made by dissolving 10 g of casein
hydrolysate, 5 g tryptone, 5 g NaCl and 1 g yeast extract in one liter of distilled water.
After sterilization, glucose and K2HPO4 were added to yield a final concentration of 11
mM and 16 mM, respectively. The full medium is named CATPG. If needed, 1.5 % (w/v)
of agar was added to the medium. Unless mentioned otherwise, pneumococcal cultures
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were grown statically in slip cap tubes at 37 ℃. To aerate pneumococcal cultures, a 1~2
ml of a pre-grown static culture was placed into a 75 ml of conical flask, incubated at 37
℃, and shaken at a speed of 200 rpm. For storage, all the pneumococcal cultures were
grown to OD550 nm=0.2-0.3, supplemented with 10% (v/v) sterile glycerol and stored at -
80 ℃.
Chemically Defined Medium
If needed, a chemically defined medium modified from Van de Rijn was used to
culture pneumococcal cells [87]. The detailed recipe is shown in Table II.
Medium for E. coli
Luria-Bertani (LB) medium was used to grow all E.coli strains. The medium was
made by dissolving 10 g of tryptone, 5 g yeast extract, and 10 g NaCl into one litter of
distilled water. The pH of the medium was adjusted to 7.5 by NaOH before sterilization.
Unless mentioned otherwise, E.coli cultures were grown in a shaking incubator at 37 ℃
at 200 rpm. If needed, 2 % (w/v) of agar was supplemented into medium. For short-term
storage, overnight cultures were stored at -20 ℃ with 50% sterile glycerol while for long-
term storage, they were kept at -80 ℃ with 10 % sterile glycerol. Antibiotics were
supplemented into the medium if needed. The concentrations of antibiotics used for
selection during culturing bacteria are listed in Table III.
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TABLE I. Bacterial Strains and Plasmids
Strains or Plasmids Description Source or reference
S. pneumoniae strains
D39 Type 2 encapsulated, virulent [77]
Rx1 Non-encapsulated laboratory strain
CP1250 malM511 str-1 β-gal- [78]
SP1000 str-1 Tn5252 Em Cm [79]
SP1400 SP1000 derivative β-gal- Tn5252 This study
SP1403 SP1400 derivative, Tn5252∆ cat This study
SP1407 SP1403 (pVJ572 Tcr) This study
SP1460 SP1407 derivative, Pm malX – Emr cassette
inserted upstream of the helix operon This study
SP1471 SP1403 derivative, Pm malX – Emr cassette
inserted upstream of the helix operon This study
SP1472 SP1403 (ORF2 of helicase operon Ω lacZ) This study
SP1476 SP1471 (ORF2 of helicase operon Ω lacZ) This study
SP1519 SP1403 derivative, Pm malX – Emr cassette
inserted upstream of the helix operon This study
SP1525 SP1403 derivative, spxB Ω lacZ This study
SP1528 SP1519 derivative, spxB Ω lacZ This study
SP3001 str-1, derivative of D39 This study
SP3003 novr derivative of D39 This study
SP3004 SP3001ΩpSS141 carrying the helicase operon Emr This study
SP3005 SP3004 (ORF2 of helicase operon Ω Kmr) This study
SP3100 novr derivative of WU2, an encapsulated serotype III
clinical strain This study
SP3101 str-1 derivative of WU2 This study
SP3102 SP3101ΩpSS141 Emr This study
SP3103 SP3102 (ORF2 of helicase operon Ω Kmr) This study





pDG647 Ampr Emr [81]
pDL278-D Spcr [82]
pDR18 pSK+::1.65 kb HindIII fragment from within




pRK1301 pACYC184::4 kb DNA carrying promoterless lacZ
of E. coli Jacques Fresco
pSJ170 Ampr Kmr [85]
pSS141 pVA891::28.1kb KpnI fragment from Tn5252 [5]
pVA891 Cmr Emr [86]
pVJ572 pLS1 (EcoRI)::1.1 kb PCR amplified DNA
carrying malR of Rx1 This study
pVJ588 pDL276-D (SmaI)::0.6 kb PCR-amplified DNA
using primers Pm-mal3/Pm-mal4 and carries
the pneumococcal malX/M promoters This study
pVJ595 pVJ588 (HindIII)::1.6kb HindIII Emr fragment
of pDG647 This study
pVJ604
pVJ605
pZH2 pSJ170 (BglII):: 4 kb BglII DNA fragment
carrying lacZ from pRK1301 This study
pZH12 pDR18 (BglII):: 5 kb BamHI DNA fragment containing
the lacZ-Kanr cassette from pZH2 This study
pZH38 pEVP3 (SmaI)::1 kb DNA amplified using
the primers, G54-1 and G54ORF1-F This study
pZH54
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β-Nicotinamide adenine dinucleonide 2.5




















Yeast extract 0.04% (w/v)
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Chemicals
Chemicals were purchased from Sigma (USA) unless mentioned otherwise.
Chromosomal and Plasmid DNA Isolation
Chromosomal DNA isolation from pneumococcus
To isolate chromosomal DNA, pneumococcal cultures were started by inoculation
of 1 ml culture stored at -80 ℃ into 100 ml CATPG, with proper antibiotics if needed
until OD550 nm ≈ 0.3. The cells were collected by centrifugation at 5,800 g in a Sorvall
GSA rotor at 4 ℃ for 10 minutes. After discarding the supernatant, the pellets were
resuspended in 4 ml of 10 mM ethylenediamine tetraacetic acid (EDTA) (pH=8.0) and
kept on ice for 10 minutes. To initiate lysis, 3 ml of lysis solution [30mM EDTA, 0.1 %
(w/v) sodium dodecyl sulfate (SDS), 0.4 % sodium deoxycholate (DOC), and 100 µl
RNase], was added. The lysis mixture was kept at 37 ℃ until the solution became clear.
Then, proteinase K was added to a final concentration of 100 µg/ml to degrade nucleases.
The solution was incubated at 65 ℃ overnight. The DNA was extracted at room
temperature with an equal volume of phenol-chloroform-isoamyl alcohol (25:24:1) for 10
minutes, twice with chloroform-isoamyl alcohol (24:1) for 10 minutes and finally
precipitated with two volumes of 95 % ethanol at -20 ℃ for at least 20 minutes. The
DNA pellet was collected by centrifugation at 6,500 g in a Sorvall GSA rotor for 20
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minutes. Then the DNA pellet was vacuum dried (Forma-Vac, Forma Scientific, Inc.),
before it was resuspended in 1 ml TE buffer [10 mM Tris-Cl (pH 7.5), 1 mM EDTA].
The DNA concentration was determined using a UV spectrophotometer (Spectronic
1001, Milton Roy Co.).
Plasmid DNA isolation from E.coli
Plasmid DNA isolation was done by using a Wizard column (Promega). Briefly, 3
ml of overnight culture was pelleted by centrifugation at 15,000 g for 30 seconds in a
bench top centrifuge (Beckman). Cells were resuspended in 0.3 ml resuspension solution
[25 mM Tris-HCl (pH=8.0), 10 mM EDTA, and 25 µg/ml RNase]. Cells were lysed by
addition of 0.3 ml of lysis solution (0.2 M NaOH, 1 % SDS) and kept at room
temperature for 5 minutes. Then the lysate was mixed with 0.3 ml of neutralization
solution [3 M potassium acetate (pH=5.2)] and kept on ice for 10 minutes. The lysate was
centrifuged at 15,000 g in bench top centrifuge machine for 10 minutes. The supernatant
was saved and mixed with resin [4 M guanidine thiocyanate, 50 mM Tris-HCl (pH=7.0),
10 mM EDTA, 10 mM diatomaceous earth] before being passed through a Wizard
column. The column was washed with 3 ml of column washing solution [100 mM NaCl,
10 mM Tris-HCl (pH=7.5), 2.5mM EDTA and 50% ethanol (v/v)]. For DNA sequencing
templates, a special washing solution [50% ethanol (v/v), 10 mM Tris-HCl (pH=7.4), 10
mM KAc, 1µM EDTA] was applied. Then samples are centrifuged at 15,000 g for 30





Genotype/Phenotype Antibiotic Stab Plate/Broth Overlay
Streptococcus pneumoniae
cat (Tn5252) chloramphenicol 5 15
Emr erythromycin 3 5
nov novobioicin 10 10
str streptocmycin 200 200
aphA (Tn1545) kanamycin 200 1000
tet (pLS1) tetracycline 1 1
Cmr (pEVP3) chloramphenicol 3 5








of preheated TE was added into column, and incubated 1 minute before a final spin at
15,000g for 1 minute to elute the DNA from the column.
Plasmid DNA isolation from pneumococcus
To isolate plasmid DNA, 20 ml of pneumococcal cells, pre-grown under selective
pressure to OD550 nm ≈ 0.3, was pelleted at 6,500 g in Sorvall GSA rotor at 4 ℃ for 10
minutes. The cells were resuspended in 0.3 ml of resuspension solution. Then the




For transformation, recipient cells (106 CFU), donor DNA (1µg/ml for
chromosomal DNA and 10 µg /ml for plasmid DNA), and 100 ng cps-1 (competence
inducing factor) were mixed into 1ml of CTM [CATPG with 0.2% (w/v) bovine serum
albumin (BSA) (USB), and 1 mM CaCl2]. The mixture was kept at 37 ℃ for 90 minutes
before addition of DNase I at a final concentration of 25 µg/ml to stop transformation.
Various dilutions of the transformation mixture were added into 4 ml of CATPG broth
with 0.1% (w/v) BSA (Fisher). Then 4 ml of agar, pre-cooled to 49 ℃, was mixed with
the broth containing the transformation mixture and poured on top of a 20 ml base
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CATPG agar. After the cell layer solidified, 10 ml of CATPG agar was overlaid (buffer
layer) and incubated for 90 min at 37 ℃ for phenotypic expression. The plate was then
overlaid with 10 ml CATPG agar containing the appropriate antibiotic and incubated at
37 ℃ overnight. If needed, 50µl of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
(X-gal), dissolved in dimethylformide (40mg/ml), was spread on the surface of base agar
prior to overlaying cell layer to identify β-galactosidase+ cells.
E.coli Transformation
E.coli competent cells were prepared and transformed according to method of
Hanahan [88]. To prepare frozen competent cells, 0.5 ml of overnight E.coli culture pre-
grown in SOB [2 % (w/v) bactotryptone, 0.5 % (w/v) yeast extract, 10 mM NaCl, 2.5
mM KCl, 10mM MgCl2, and 10 mM MgSO4] was inoculated into 50 ml of SOB. After
precisely two and half hours, the culture was transferred to ice and incubated for 15
minutes. Cells were then pelleted at 5,800 g for 10 min at 4 ℃. The supernatant was
discarded and cells were resuspended in 8 ml of ice cold FSB [10 mM KAc, 100 mM
KCl, 45 mM MnCl2, 10 mM CaCl2, 3 mM hexamine cobalt and 10 % (v/v) redistilled
glycerol]. The cells were kept on ice for 15 minutes and then pelleted again at 5000 g for
10 minutes at 4 ℃. The supernatant was discarded and cells were resuspended in 2ml of
FSB. After addition of 70 µl of DMSO, the cells were kept on ice for 5 minutes, another
70 µl of DMSO added, and incubated on ice for another 10 minutes. The cells were
dispensed in volume of 200 µl volume into pre-chilled eppendoff tubes and stored at -80
℃.
32
For transformation, the frozen competent cells were thawed on ice. After addition
of donor DNA (less than 10 µl in volume per 200µl of cells), the mixture was kept on ice
for 30 minutes. The cells were given a heat shock at 42 ℃ for 90 seconds and transferred
to ice immediately for 2 minutes. After addition of 800 µl of SOC (20 mM glucose in
SOB), the cells were transferred to shaking incubator at 37 ℃ for 1 hour phenotypic
expression. Finally cells were spread on LB plate with the appropriate selective
antibiotic. Plates were incubated at 37 ℃ for 16-24 hours. If needed, before spreading the
cells, 50µl of X-gal solution (40mg/ml) was spread on the surface of LB plate.
DNA Manipulations
Cloning
Restriction enzyme digestion were carried out by mixing 1-5 µg of DNA with 10-
50 Units of restriction enzyme in the appropriate buffer. The total volume for each
restriction digest reaction varied from 50 µl to 200 µl. After digestion, 1/20-1/10 of total
digested DNA was analyzed by agarose gel electrophoresis, while the remaining was
cleaned up by phenol-chloroform extraction and ethanol precipitation.
After digest, if needed, Klenow fragment of E. coli DNA polymerase I was used
to convert the sticky ends to blunt ends. In a reaction mixture, 5 µg of digested DNA was
mixed with Klenow buffer and 1 unit of Klenow fragment of DNA polymerase I in a final
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volume of 40 µl. The reaction mixture was incubated at 37 ℃ for 15 minutes before
phenol-chloroform-isoamyl alcohol extraction and ethanol precipitation.
Ligation was carried out in 10-20 µl volume by mixing ligase buffer, T4 DNA
ligase, vector DNA and insert DNA (in the ratio of 1:3). The ligation mixture was then
incubated at 16 ℃ overnight and 4 ℃ for one extra day before transformation.
Agarose Gel Electrophoresis
DNA samples were analyzed by separation on horizontal agarose gels at room
temperature. Agarose gels were made by mixing 1/2X TBE (45 mM Tris-borate, and 1
mM EDTA, pH=8.3) with 0.8 % (w/v) of agarose. DNA samples to be analyzed were
mixed with 10 % (v/v) loading buffer [5 % (v/v) glycerol, 3 mM EDTA (pH=8.0),
bromophenol blue (0.04 %) and xylene cyanol (0.04 %)] before loading on the gel. The
gels were run at 5 volts/cm constant electric current until the forward dye reached 1 cm
away from the bottom. After electrophoresis, the gel was soaked in distilled containing
ethidium-bromide (1 µg/ml) for 10 minutes to stain DNA and in distilled water for 10
minutes for destaining. The gel images were photographed using an Alpha Imager (Alpha
Innotech Corporation). Molecular weight standards (1 kb ladder from BRL) were run
along for size reference.
Preparative mini-gels were used to purify DNA fragments of specific sizes. In this
case, agarose gels were made with ultra-pure agarose (Bio-Rad). After electrophoresis,
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staining and destaining were carried out as above, and a slice of gel slice containing the
DNA was electroeluted and purified according to Sambrook [89].
Conjugation
Conjugation between pneumococcal donors and recipients was performed
according to the method described by Smith and Guild [90] with minor modifications.
Briefly, both donor and recipient cells were grown to an OD550nm ≈ 0.2 in DIFCo
CATPG. The donor and recipient cells were mixed in ratio of 1:10. MgSO4, BSA, and
DNase I were added to final concentrations of 10 mM, 2 mg/ml and 5 mg/ml,
respectively. Altogether 1 X 109 CFU cells were then filtered onto a nitrocellulose filter
(Millipore: 13mm diameter and 45 µm pore size). The filter was placed with cell side
down on Difco CATPG agar with additional 10 mM MgSO4, 2 mg/ml BSA, 1 mM CaCl2
and 100 µg/ml of DNase I, and agar with the same components was overlaid on top. After
the top agar solidified, the plate was moved to a 37℃ incubator and incubated for 4
hours. Then the filter was cut out with both layers of agar and transferred into 3 ml of
resuspension broth (CATPG with 10 mM MgSO4, 2 mg/ml BSA, 100 µl/ml DNase I and
10 % glycerol). The cells from the filter were harvested by votexing vigorously, and the




DNA samples for blotting were firstly digested with appropriate restriction
enzymes, and fragments separated on 0.8 % agarose gels by electrophoresis. The gel was
stained, destained, and placed under UV light for 30 seconds to break the large fragments
of DNA into smaller fragments to increase blotting efficiency. The gel was then soaked
in 300 ml denaturation solution (0.4 M NaOH and 0.6 M NaCl) for 30 minutes. After
denaturation, the gel was soaked into 300 ml neutralization solution (0.5M Tris-HCl and
1.5M NaCl) for 30 minutes. After neutralization, in a big glass tray, enough 10X SSC,
was added to soak a pair of sponges. On top of the sponges, 3 layers of filter paper, the
gel containing the DNA for blotting, a pre-cut nylon membrane (GeneScreen Plus, NEN),
a second layer of three filter papers, 3 inches of paper towels, and finally a 1 kg weight
were overlaid in order. In this setup, DNA was transferred to the nylon membrane
successfully through capillary action during overnight incubation.
Pre-hybridization
After blotting, the nylon membrane was transferred to a hybridization tube with
10 ml of pre-hybridization solution (1 g dextran sulfate, 0.58 g NaCl, 1 ml 10 % SDS and
8 ml ddH2O). The hybridization tube was kept at 65 ℃, rotating overnight.
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Nick Translation
Probe DNA was nick-translated as follows, in a 50 µl mixture: 0.5 µl of DNase I
(0.5 µg/ml), 5 µl of 10X dNTP without dATP (5 µM for each of dCTP, dGTP and dTTP),
5 µl α-32P- dATP (10 mCi/ml), and 0.5 µl of E.coli DNA polymerase I (9000 U/ml). The
mixture was kept at 16 ℃ for 2 hours. The reaction was terminated by addition of 25 µl
of 0.5 M EDTA (pH=8.0), 25 µl of salmon sperm DNA (2 mg/ml), 50 µl of 7.5 M
ammonium acetate, and 50 µl of TE. The DNA was then precipitated by addition of
another 400 µl of 95 % ethanol, kept at -20 ℃ for 15 minutes. The DNA was pelleted,
dried, and resuspended in 600 µl of TE. To determine the efficiency of isotope
incorporation, 1 µl of labeled DNA was mixed with 5ml of liquid scintillation cocktail
(Beckman) and the radioactivity was counted in a LS6000SC liquid scintillation counter
(Beckman).
Hybridization
Labeled probe DNA (2*106 CPM) was added to a screw-cap tube with 10 ml
hybridization solution [100 µl of 20X SSC, 400µl of salmon sperm DNA (2 mg/ml) in 10
ml]. After boiling for 10 minutes, the screw-cap tube was immediately transferred to ice
bath for 3 minutes. Hybridization was carried out by addition of 10 ml of hybridization
solution into the hybridization tube containing the membrane. The tube was incubated at
65 ℃, rotating for 18 hours. After discarding hybridization solution, the membrane in the
hybridization tube was washed twice with 2X SSPE [17.53 % (w/v) NaCl, 2.76 % (w/v)
37
TABLE IV. Oligonucleotides used in this study*
________________________________________________________________________
647 Em-F  5’-CGATCCTAATAAATTTAAATATCAAAAAGAAGAT
647 Em-R  5’-TCCTTTAACTCTGGCAACCCTCAAAATT
G54-1   5’-TTGAGTCAACCATTAGAAGAAATTCCTC














*Lower case letters indicate the extra bases added to create the restriction endonuclease
sites.
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NaH2PO4 and 0.74 % (w/v) EDTA (pH=8.0)], for 15 minutes at room temperature, twice
with 2X SSPE containing 2% SDS for 45 minutes at 65 ℃, twice in 0.1X SSPE for 30
minutes at room temperature, and once in 3 mM Tris base (unbuffered) solution for 15
min at room temperature. The membrane was dried in a 37 ℃ oven and exposed to X-ray
film (Kodak X-Omat AR) at -80 ℃. The exposed film was developed in the Core Facility
at Oklahoma State University.
Polymerase Chain Reaction
Polymerase chain reaction (PCR) was performed in an Eppendorf Mastercycler
Personal thermal cycler. DNA polymerase used in PCR was deep vent polymerase (New
England Biolabs). All the oligonucleotides used for PCR are listed in Table IV. In each
cycle of the PCR reaction, 94℃ was used to denature DNA. The annealing temperature
in reactions was at least 5 ℃ lower than the Tm of the primer with the lowest Tm. A
ramp temperature of 0.3 ℃/minute was applied during annealing. The polymerization
temperature was 72 ℃. About 25~30 cycles were run before samples were loaded on
preparative gel to purify the amplified DNA.
Virulence assays
For animal model systems, 6 week old female Balb/c mice (Charles River
Laboratories, Massachusetts), weighing 25-30 g were used. Bacteria used for infection
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were pre-grown to a density of OD550~0.1. The cells were pelleted, resuspended in the
same volume of phosphate buffered saline (8 g NaCl, 0.2 g KCl, 0.2 g KH2PO4, and 0.92
g NaH2PO4 in 1 liter of distilled water) with 10 % glycerol, and stored in -80 ℃. The
cells were thawed on ice and, if needed, they were diluted in PBS and used for infections.
Animal experiments were performed in accordance with the guidelines of
Oklahoma State University Institutional Animal Care and Use Committee. For septicemia
infection, the pre-stored cultures were diluted to about 1000 cfu/ml and 200 µl injected
intraperitoneally. For intranasal infection, mice were lightly anaesthetized with isoflurane
(Abbott Laboratories) inhalation and inoculated with 5X105 CFU in 50 µl. Infected mice
were monitored for at least 7 days for signs of morbidity and mortality, and in the end,
the survivors were euthanized by CO2 overdose.
Competition experiment
In vivo intranasal competition experiments were performed by inoculation of
anaesthetized mice with a bacterial suspension consisting of a 1:1 mixture of the two
differentially genetically marked strains (nov vs str) at a density of 106 cfu. Starting at 12
hours post infection, samples were collected by instilling one nostril with 400 µl of sterile
PBS and recovering about 200 µl effluent through the other nostril. 100 µl of effluent was
mixed with 1.9 ml CAT broth with 10% glycerol and stored at -80 ℃ until plating. For
intraperitoneal competition experiments, a 200 µl bacterial suspension containing
approximately 1-2 X 104 CFU of each bacterium in a 1:1 mixture was injected into mice.
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At 24 hours post infection, 5 µl of blood was collected by retro orbital puncture and
mixed with 2 ml CAT broth containing 10 % glycerol and stored at -80 ℃ until plating.
For plating of nasal washings and cultures from blood, gentamycin (4 µg/ml) was
included in all the plates in addition to other antibiotic selections.
Competition experiments in vitro were preformed by co-culture of two strains
each at about the same density. At different time points, part of the mixture was diluted
and plated out under appropriate antibiotic selection to distinguish the viable count of
each strain.
Transcriptional Gene Fusion
To determine the transcriptional profile of a gene of interest, gene fusions
involving lacZ were created as follows. Firstly, a fragment of DNA totally internal to the
gene of interest was amplified by PCR using appropriately designed primers. The
amplified DNA was then cloned into the SmalI site of pEVP3. The recombined plasmid
was sequenced by using primers flanking the insertion site to confirm that lacZ in the
recombined plasmid was in the same orientation as the transcription of the gene of
interest. Finally, the recombined plasmid, without linearization, was used as donor DNA
to transform a Cms pneumococcal strain. The resulting Cmr transformants were expected
to have the directing DNA duplicated flanking the inserted plasmid.
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β- Galactosidase assay
These assays were carried out as previously reported [78] with slight
modifications. Pneumococcal cells were grown to an optical density as required by each
specific experiment. To initiate lysis of the cells, 20 µl of lysis solution [1 0% (v/v) triton
with 0.04 % DOC (w/v) in distilled water] was added to each culture. The lysis mixture
was incubated at 37 ℃, until the solution became clear. To start the β-galactosidase
reaction, 0.5 ml lysate, 0.2 ml of ONPG (10 mg/ml) and 0.5 ml of Z buffer (1.61 g
Na2HPO4
.7H2O, 0.55 g NaH2PO4
.H2O, 0.075 g KCl, 0.025 g MgSO4
.7H2O and 0.27 ml
β-mercaptoethanol in 100 ml distilled water) was mixed into a 1 ml disposable cuvette.
The cuvettee was incubated at room temperature until a yellow color was developed. To
stop the reaction, 0.5 ml Na2CO3 (0.5 M) was added to the reaction mixture and, the
optical density at 420nm was measured in a spectrophotometer (Spectronic 1001, Milton
Roy Co.). Miller units were calculated according to the formula: Miller unit=
1000*OD420/time of reaction (minute)/volume of lysate used in reaction (ml)/OD550 (cell
density)
Hydrogen peroxide susceptibility assays
These assays were carried out as described [15]. Pneumococcal cultures were
grown until the OD550 of the cultures reached precisely 0.1. The culture was then
immediately diluted 1000-fold. The assay was started by addition of H2O2 to 1ml of
diluted culture to make a final concentration of 10 mM. Another 1 ml of diluted culture
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without addition of H2O2 was used as a control. Both tubes were kept at 37 ℃ for 30
minutes and then transferred to an ice-bath until plating. Appropriate dilutions were made
before being mixed with agar and plated out on top of a CATPG base layer. Finally 10 ml
of CATPG-agar with streptomycin (200 µg/ml) was overlaid on top of the cell layer. The
percent of survival rate was calculated by dividing the number of cells surviving after
exposure to H2O2 by the number of cells surviving in the control without exposure to
H2O2. Similarly, to determine sensitivity of pneumococcus in other oxidative regents,
pncumococcal cultures were grown and diluted as described above. Then methyl
viologen or tert-butyl hydroperoxide were supplemented to final concentrations of 30
mM and 40 mM, respectively. Survival rates were calculated in the same way as
mentioned above.
Hydrogen peroxide production assay
Assays were carried out as described by Pericone et al[15]. Pneumococcal
cultures were grown until the OD550 reached 0.2. The cells were then pelleted and
resuspended in twice the volume of fresh medium. Cell density was determined by
measurement of OD550. The cells were incubated in the desired condition (static or
aerobic) for 1 hour. Cells were then pelleted again, and the supernatant was saved to
determine the concentration of H2O2. The assay was performed as follows. In a 1 ml
disposable cuvette, 100 µl of the supernatant for aerated culture (900 µl of supernatant
for static culture), 100 µl of dyes [3 mg/ml of 2, 2_azinobis (3-
ethylbenzthiazolinesulfonic acid) and 0.2 mg.ml horseradish peroxidase] were mixed
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with CAT to a final volume to 1 ml. The reaction mixture was incubated at room
temperature for 20 minutes and optical density at 560nm then determined by
spectrophotometry (Spectronic 1001, Milton Roy Co.). Finally H2O2 concentration was
calculated by comparison of the OD560 to a standard curve generated by using known
concentrations of H2O2.
Examination of Colony Morphology in Pneumococcal
Encapsulated Strains
Examination of colony morphology in pneumococcal encapsulated strains was
carried out as described by Weiser et al [91]. Briefly pneumococcal cultures were
streaked out on blood agar (CATPG with 2% sheep supplemented) allowing overnight
incubation in an anaerobic jar. The next day, the plate was placed under a 100-W halogen
substage illuminator to examine colony morphology. Colony of transparent variant
appears “smaller, bluish, and more transparent in the center” ("bullseye"), while opaque




Features of the methylase/helicase operon in Tn5252
Recently, the genomic sequence of a clinical isolate of pneumococcus carrying
multiple antibiotic resistance, G54, was published [92]. To determine if antibiotics
resistance in G54 was determined by a Tn5252-like transposon, we used the sequence of
Tn5252 to search the whole genomic sequence of G54
(http://bioinformatica.cnio.es/data/Spneumo/). A Tn5252-like transposon, with almost
identical transfer-related genes residing in the termini, was identified in the G54 genomic
sequence. Besides the transfer-related genes of the Tn5252-like transposon in the G54
genome, an operon was also present in the central region of the element, and the deduced
amino acid sequence was almost identical to that from the central segment of Tn5252.
The operon had a G+C content of 35.1% which was close to the G+C content range of
streptococci (35.6%~39.8%). This 7.8 kb region of G54 Tn5252-like element is shown in
Fig 2. There are four open reading frames. Upstream of each open reading frame, there
was a putative ribosome-binding site. A Gram-positive consensus promoter-like sequence
was also observed about 120 bases upstream of the translational start site of ORF1. The
sequence between each open reading frame was less than 100 bp and there were no
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consensus promoter-like sequence observed upstream of ORF2, ORF3 or ORF4,
implying that these four open reading frames are transcribed as one transcriptional unit.
ORF1, ORF3 and ORF4
ORF1, ORF3 and ORF4 have the capacity to encode proteins with 136, 94 and 98
amino acids, with molecular masses of 15.4, 11.3 and 11.4 kDa, respectively. Blast
search using the deduced amino acid sequences of ORF1, ORF3 and ORF4 revealed the
presence of nearly identical sequences in S. suis 89/1591 (accession #
AAFA02000007.1), S. agalactiae NEM316 (gbs1355, gbs 1351, and gbs1350
respectively) and S. agalactiae 2603V/R (sag1281, sag 1279, and sag1278 respectively).
Analysis of the deduced amino acid sequences suggests cytoplasmic localization of the
ORF1 and ORF3 proteins, and membrane localization of the ORF4 protein. A Ca2+-
binding motif was also present in the protein encoded by ORF1. Proteins encoded by
ORF1, ORF3 and ORF4 did not seem to belong to any protein family of known function.
ORF2
Quite different from ORF1, ORF3 and ORF4, ORF2 had the capacity to encode a
much larger protein of 2074 amino acids with a molecular weight of 239.8 kDa. Analysis
of the deduced amino acid sequence suggests the cytoplasmic localization of this protein.
Unlike ORF1, ORF3 and ORF4, the amino acid sequence of ORF2 has significant
similarity to sequences from a variety of sources, such as SAG 1280 from S. agalactiae
260 V/R, gbs 1352 from S. agalactiae NEM 316, EF2307 from Enterococcus faecalis
46
Fig 2. The nucleotide sequence of the 7.8 kb sequence of the
helicase operon and the deduced amino acid sequences of ORF1, ORF2,
ORF3 and ORF4. The ribosome binding site (RBS) of each of ORF is
shown upstream of start codon.
10 20 30 40 50
AATCTTTATTAGATTTGAAGAGAAAGACAGTATTTCCAAAAGGTCAAAAA
TTAGAAATAATCTAAACTTCTCTTTCTGTCATAAAGGTTTTCCAGTTTTT
60 70 80 90 100
GTAATTTCAATTTACTCAAAACATTTACAAACATCGGAACTTTTTTATTA
CATTAAAGTTAAATGAGTTTTGTAAATGTTTGTAGCCTTGAAAAAATAAT
110 120 130 140 150
TTTAAAAGATTAGTTTACATATCTTTTGTGGTATAAAATATATTTTTATC
AAATTTTCTAATCAAATGTATAGAAAACACCATATTTTATATAAAAATAG
160 170 180 190 200
ATTTTCAGGAGAACGCAGTTTTGGCTCGTTCTCTTTTTTTGTTGTGATAC
TAAAAGTCCTCTTGCGTCAAAACCGAGCAAGAGAAAAAAACAACACTATG
210 220 230 240 250
TTCTTTCAAGGAATATTTGGTAGGATTGGAGTGAAAAAAAATTAACTAGG
AAGAAAGTTCCTTATAAACCATCCTAACCTCACTTTTTTTTAATTGATCC
260 270 280 290 300
AAAGAAGGAAGTATATGGAAGCCATTTATCAACGTGATTCGGATCAAGAT
TTTCTTCCTTCATATACCTTCGGTAAATAGTTGCACTAAGCCTAGTTCTA
M E A I Y Q R D S D Q D
310 320 330 340 350
GGATTAACTGATGCTCAAGAATTGGCCCTAGGAACCAATCCTCTTAGCTC ORF1
CCTAATTGACTACGAGTTCTTAACCGGGATCCTTGGTTAGGAGAATCGAG
G L T D A Q E L A L G T N P L S S
360 370 380 390 400
AGATTCTGATGGTGATGGACGTTCAGATTTAGTGGAAATAGAAGAAGGAA
TCTAAGACTACCACTACCTGCAAGTCTAAATCACCTTTATCTTCTTCCTT
D S D G D G R S D L V E I E E G
410 420 430 440 450
CCAATCCCTTAGAAAAGGATTTACAAGACATAGACCAAACAAGTATCACT
GGTTAGGGAATCTTTTCCTAAATGTTCTGTATCTGGTTTGTTCATAGTGA
T N P L E K D L Q D I D Q T S I T




E S S S V F M E M K Q K I S D M M
510 520 530 540 550
GGAGAGTCACTACAAGGAATTTATACTGGCTCTGATTAGTATTGAAACAG
CCTCTCAGTGATGTTCCTTAAATATGACCGAGACTAATCATAACTTTGTC
E S H Y K E F I L A L I S I E T
560 570 580 590 600
GGATTGAAAACCAACAAGACCTAGAAGACTTATATACTTACTACATGAGA
CCTAACTTTTGGTTGTTCTGGATCTTCTGAATATATGAATGATGTACTCT
G I E N Q Q D L E D L Y T Y Y M R
610 620 630 640 650
ATGGATGCCGTTTCTCTTTTATCTAGTGATTTAGAAACCAGTCCTCAAGA
TACCTACGGCAAAGAGAAAATAGATCACTAAATCTTTGGTCAGGAGTTCT
M D A V S L L S S D L E T S P Q E
660 670 680 690 700 ORF1
GGTTGAAATGGAGATAGAGTTGTAGGGGAATCATGTGATTCTCCTATTTT
CCAACTTTACCTCTATCTCAACATCCCCTTAGTACACTAAGAGGATAAAA
V E M E I E L *>
710 720 730 740 750
CGTATAGATGAAAGGAGCGAGTATGGAAGTAATACAATTATTGGCTATGT
GCATATCTACTTTCCTCGCTCATACCTTCATTATGTTAATAACCGATACA
M E V I Q L L A M
760 770 780 790 800 ORF2
TTCGTGGAACAATTCCAAAAGATAGGGATAAAATGGACCTATTTCTTCGC
AAGCACCTTGTTAAGGTTTTCTATCCCTATTTTACCTGGATAAAGAAGCG
F R G T I P K D R D K M D L F L R
810 820 830 840 850
TATCAGGCGCAACATTTTGATGAGAAATGGCAGGACTTGGTAGAGAGTTT
ATAGTCCGCGTTGTAAAACTACTCTTTACCGTCCTGAACCATCTCTCAAA
Y Q A Q H F D E K W Q D L V E S F
860 870 880 890 900
TTTGACTGAAGAGGAGAAGATAGAAGAGATACCTCATGTCTATTCGTTTC
AAACTGACTTCTCCTCTTCTATCTTCTCTATGGAGTACAGATAAGCAAAG
L T E E E K I E E I P H V Y S F
910 920 930 940 950
ATCAAGACATTGTTTCTTTCCTAGAGGCCAGTTCTGAAAATAATGACCAA
TAGTTCTGTAACAAAGAAAGGATCTCCGGTCAAGACTTTTATTACTGGTT
H Q D I V S F L E A S S E N N D Q
960 970 980 990 1000
GATCTAGAAAGTTACACAAGAAATTTTGGACAAGCAGGACTAGATAAATT
CTAGATCTTTCAATGTGTTCTTTAAAACCTGTTCGTCCTGATCTATTTAA
D L E S Y T R N F G Q A G L D K L
48
1010 1020 1030 1040 1050
ATCTCAATTAAGTAATTTTGAGAAAAATTTGGTGCTAAAAGTCGCAAGCT
TAGAGTTAATTCATTAAAACTCTTTTTAAACCACGATTTTCAGCGTTCGA
S Q L S N F E K N L V L K V A S
1060 1070 1080 1090 1100
ATAACCTTTCCACTCGATTTTACATCCAATCTGAAAAAGAGAAACTAACA
TATTGGAAAGGTGAGCTAAAATGTAGGTTAGACTTTTTCTCTTTGATTGT
Y N L S T R F Y I Q S E K E K L T
1110 1120 1130 1140 1150
CCATTAAGTGAGCTTGTATTTCATCAGAATCAGGATGTTAATTTAGTCAA
GGTAATTCACTCGAACATAAAGTAGTCTTAGTCCTACAATTAAATCAGTT
P L S E L V F H Q N Q D V N L V N
1160 1170 1180 1190 1200
TGTCTATCGGGTTGCGAATAATCTATCTGACCGTATTAGTAGAGATATAG
ACAGATAGCCCAACGCTTATTAGATAGACTGGCATAATCATCTCTATATC
V Y R V A N N L S D R I S R D I
1210 1220 1230 1240 1250
AGGAATTTCTTCTAATGGTTGACTCAAAAGAGGTTAAAAAAGAAGTTCCT
TCCTTAAAGAAGATTACCAACTGAGTTTTCTCCAATTTTTTCTTCAAGGA
E E F L L M V D S K E V K K E V P
1260 1270 1280 1290 1300
GAGATTCATTTTGAAGAAAAAGAGGGAGATGTTCTAGCCTATTTGGGTTC
CTCTAAGTAAAACTTCTTTTTCTCCCTCTACAAGATCGGATAAACCCAAG
E I H F E E K E G D V L A Y L G S
1310 1320 1330 1340 1350
AGAATTGATGGCTACTTTAGATATCGTTACGGATCTTGTCCATCATGAAG
TCTTAACTACCGATGAAATCTATAGCAATGCCTAGAACAGGTAGTACTTC
E L M A T L D I V T D L V H H E
1360 1370 1380 1390 1400
AAAACTACATACAACTCCCACTGACACAAAAGCTGAAGATTATTACTCAT
TTTTGATGTATGTTGAGGGTGACTGTGTTTTCGACTTCTAATAATGAGTA
E N Y I Q L P L T Q K L K I I T H
1410 1420 1430 1440 1450
TTTGATGAAGTAAAAGCTAAAAGCGAAAAGTCTAATCAAGTAGAGAAAAT
AAACTACTTCATTTTCGATTTTCGCTTTTCAGATTAGTTCATCTCTTTTA
F D E V K A K S E K S N Q V E K I
1460 1470 1480 1490 1500
TTTATCTCCTTCAAGTGATATTGAACAGGAAACGGAAGAAACTAACTCCT
AAATAGAGGAAGTTCACTATAACTTGTCCTTTGCCTTCTTTGATTGAGGA
L S P S S D I E Q E T E E T N S




F S N V D K I V E E A L R E Y P I
1560 1570 1580 1590 1600
GGTTCACAAGTAAGTTATAAAGGACAAGTATTTCAGTTGGTTTCGATTGA
CCAAGTGTTCATTCAATATTTCCTGTTCATAAAGTCAACCAAAGCTAACT
G S Q V S Y K G Q V F Q L V S I E
1610 1620 1630 1640 1650
AAATGCGCAGTTAAATGACTTAGTTCGCCTAGAGCTATTCAATGATTCCA
TTTACGCGTCAATTTACTGAATCAAGCGGATCTCGATAAGTTACTAAGGT
N A Q L N D L V R L E L F N D S
1660 1670 1680 1690 1700
ACCAGTTATTTGAAGAGAATCCTATCTTATACTTGAACAGTTTGGAAGAG
TGGTCAATAAACTTCTCTTAGGATAGAATATGAACTTGTCAAACCTTCTC
N Q L F E E N P I L Y L N S L E E
1710 1720 1730 1740 1750
ATTGAACAAGTATTGTCTCATTTAGAACTTGAAAAAGAAGATTCAGAGAT
TAACTTGTTCATAACAGAGTAAATCTTGAACTTTTTCTTCTAAGTCTCTA
I E Q V L S H L E L E K E D S E I
1760 1770 1780 1790 1800
TGAGATTGATTCATCAAGTGAAAGTCAGGAAATAGATTTGTTTTCATACC
ACTCTAACTAAGTAGTTCACTTTCAGTCCTTTATCTAAACAAAAGTATGG
E I D S S S E S Q E I D L F S Y
1810 1820 1830 1840 1850
TGGAAGAAGAAAATGTAAATGAAAAGGATAAGGATAAGGAAACAAAATCT
ACCTTCTTCTTTTACATTTACTTTTCCTATTCCTATTCCTTTGTTTTAGA
L E E E N V N E K D K D K E T K S
1860 1870 1880 1890 1900
TTAATTTCAGGTATAGAAGAGACGGATGTCCCTGTTCTAGATTTTGTTTT
AATTAAAGTCCATATCTTCTCTGCCTACAGGGACAAGATCTAAAACAAAA
L I S G I E E T D V P V L D F V F
1910 1920 1930 1940 1950
TCCAGATGATTTAGAGGACTTTTATCCTAAGACAAATCGAGAAAAGATTG
AGGTCTACTAAATCTCCTGAAAATAGGATTCTGTTTAGCTCTTTTCTAAC
P D D L E D F Y P K T N R E K I
1960 1970 1980 1990 2000
AAACGAATATCGCCGCAATTGAACTTGTTAAAAGATTAGAAAAAGAGAGA
TTTGCTTATAGCGGCGTTAACTTGAACAATTTTCTAATCTTTTTCTCTCT
E T N I A A I E L V K R L E K E R
2010 2020 2030 2040 2050
CGACAAGCGAATCCAGAAGAACAAGAGCTACTCGCCAAGTATGTCGGCTG
GCTGTTCGCTTAGGTCTTCTTGTTCTCGATGAGCGGTTCATACAGCCGAC
R Q A N P E E Q E L L A K Y V G W
50
2060 2070 2080 2090 2100
GGGCGGTCTTGCCAATGAATTTTTCGATGAACTCAATCCAAAGTATGAAA
CCCGCCAGAACGGTTACTTAAAAAGCTACTTGAGTTAGGTTTCATACTTT
G G L A N E F F D E L N P K Y E
2110 2120 2130 2140 2150
CAGAACGTTTAACTCTTAAGAGCTTAGTAAGTAAATCAGAATACTCGACC
GTCTTGCAAATTGAGAATTCTCGAATCATTCATTTAGTCTTATGAGCTGG
T E R L T L K S L V S K S E Y S T
2160 2170 2180 2190 2200
ATAAAACAAAGTTCTCTCACAGCCTATTATACAGACCCAATGATTATTCG
TATTTTGTTTCAAGAGAGTGTCGGATAATATGTCTGGGTTACTAATAAGC
I K Q S S L T A Y Y T D P M I I R
2210 2220 2230 2240 2250
CCAGATTTGGCAAAAATTACTGGATGATGGTTTTGAGGGAGGAAGGATAT
GGTCTAAACCGTTTTTAATGACCTACTACCAAAACTCCCTCCTTCCTATA
Q I W Q K L L D D G F E G G R I
2260 2270 2280 2290 2300
TAGATCCTTCTATGGGGACTGGGAACTTCTTTGCGGCGATGCCTAGAAGT
ATCTAGGAAGATACCCCTGACCCTTGAAGAAACGCCGCTACGGATCTTCA
L D P S M G T G N F F A A M P R S
2310 2320 2330 2340 2350
ATACGAGAGAAATCAGAACTCTATGGGGTTGAATTAGACAGTGTGACTGG
TATGCTCTCTTTAGTCTTGAGATACCCCAACTTAATCTGTCACACTGACC
I R E K S E L Y G V E L D S V T G
2360 2370 2380 2390 2400
TGCAATCGCAAAACAACTCCACCCCAATACCCATATTGAAGTGCGAGGAT
ACGTTAGCGTTTTGTTGAGGTGGGGTTATGGGTATAACTTCACGCTCCTA
A I A K Q L H P N T H I E V R G
2410 2420 2430 2440 2450
TTGAAGAAGTTCCCTATCAAAATAATAGTTTTGATTTAGTCTTAACGAAT
AACTTCTTCAAGGGATAGTTTTATTATCAAAACTAAATCAGAATTGCTTA
F E E V P Y Q N N S F D L V L T N
2460 2470 2480 2490 2500
GTTCCTTTTGGAAATTTTCGCATTGCCGATAAAAACTATGATAAACCTTA
CAAGGAAAACCTTTAAAAGCGTAACGGCTATTTTTGATACTATTTGGAAT
V P F G N F R I A D K N Y D K P Y
2510 2520 2530 2540 2550
TATGATTCATGATTACTTTGTCAAACACTCACTTGATTTAGTAAGAGACG
ATACTAAGTACTAATGAAACAGTTTGTGAGTGAACTAAATCATTCTCTGC
M I H D Y F V K H S L D L V R D




G G Q V S I I S S I G T M D K R T
2610 2620 2630 2640 2650
GATAATGTCTTACAAGAGATTAAATCCAATACTCATTTTTTAGGGGGAGT
CTATTACAGAATGTTCTCTAATTTAGGTTATGAGTAAAAAATCCCCCTCA
D N V L Q E I K S N T H F L G G V
2660 2670 2680 2690 2700
TCGGTTGCCGGATACGGCTTTTAAAAAGATTGCAGGTACCCGAGTGACCA
AGCCAACGGCCTATGCCGAAAATTTTTCTAACGTCCATGGGCTCACTGGT
R L P D T A F K K I A G T R V T
2710 2720 2730 2740 2750
CAGATCTCCTATTCTTTCAAAAGGATCAAGCAAAGAATCTTAATGAGGAG
GTCTAGAGGATAAGAAAGTTTTCCTAGTTCGTTTCTTAGAATTACTCCTC
T D L L F F Q K D Q A K N L N E E
2760 2770 2780 2790 2800
GAACTTGTCTTTAGTGGCTCTGTTCCCTTTGAGGAGGATAAGCGTGTCTG
CTTGAACAGAAATCACCGAGACAAGGGAAACTCCTCCTATTCGCACAGAC
E L V F S G S V P F E E D K R V W
2810 2820 2830 2840 2850
GATCAATCCTTATTTTGATGGGAAATACAATACACAAGTTTTGGGTGAAT
CTAGTTAGGAATAAAACTACCCTTTATGTTATGTGTTCAAAACCCACTTA
I N P Y F D G K Y N T Q V L G E
2860 2870 2880 2890 2900
ATGAGGTACGTAATTTTAATGGAGGAACCCTCAATGTTAAGGGGGAATCA
TACTCCATGCATTAAAATTACCTCCTTGGGAGTTACAATTCCCCCTTAGT
Y E V R N F N G G T L N V K G E S
2910 2920 2930 2940 2950
GAAACATTAGCTACTGACATAATGAAAGCATTAGAGAATGTAGAAGCACC
CTTTGTAATCGATGACTGTATTACTTTCGTAATCTCTTACATCTTCGTGG
E T L A T D I M K A L E N V E A P
2960 2970 2980 2990 3000
TAAACAAATTGACAATTCTTTGAAAGCACCTGTTTTTATCCAAGAAGAAG
ATTTGTTTAACTGTTAAGAAACTTTCGTGGACAAAAATAGGTTCTTCTTC
K Q I D N S L K A P V F I Q E E
3010 3020 3030 3040 3050
TGGATAATTCTATCCCAAGTCATATACGTGAGAACTTAGCGCTCTATTCT
ACCTATTAAGATAGGGTTCAGTATATGCACTCTTGAATCGCGAGATAAGA
V D N S I P S H I R E N L A L Y S
3060 3070 3080 3090 3100
TTTGGATATGAGGGAAATCAAATTTATTATCGAGATACGCATGGCATTCG
AAACCTATACTCCCTTTAGTTTAAATAATAGCTCTATGCGTACCGTAAGC
F G Y E G N Q I Y Y R D T H G I R
52
3110 3120 3130 3140 3150
GAGAAGTTCAAAAGTAGACGAAATTAGTTATTATGTAGATGAGAAGGGAG
CTCTTCAAGTTTTCATCTGCTTTAATCAATAATACATCTACTCTTCCCTC
R S S K V D E I S Y Y V D E K G
3160 3170 3180 3190 3200
ATTTTAAAGCTTGGGACAGTTCCTTGTCTGAACATAAAATAGATCGATTC
TAAAATTTCGAACCCTGTCAAGGAACAGACTTGTATTTTATCTAGCTAAG
D F K A W D S S L S E H K I D R F
3210 3220 3230 3240 3250
GTGCAACTTCATTTGACAGATGAGGAAGCACTAGATGTATACAAGTCAGA
CACGTTGAAGTAAACTGTCTACTCCTTCGTGATCTACATATGTTCAGTCT
V Q L H L T D E E A L D V Y K S E
3260 3270 3280 3290 3300
AGAAGCGAGTAAAAGAGGGAAATATAAGGGCTTGTTCAAAAAAACGGTCT
TCTTCGCTCATTTTCTCCCTTTATATTCCCGAACAAGTTTTTTTGCCAGA
E A S K R G K Y K G L F K K T V
3310 3320 3330 3340 3350
TTTATGAAAGCCCCTTATCGGATAAGGATATTAGTCGCATTAAGGGCATG
AAATACTTTCGGGGAATAGCCTATTCCTATAATCAGCGTAATTCCCGTAC
F Y E S P L S D K D I S R I K G M
3360 3370 3380 3390 3400
GTTGATTTGAGAGAGACCTATCAAGCCTTAATTGAAATTCAACGCCATCC
CAACTAAACTCTCTCTGGATAGTTCGGAATTAACTTTAAGTTGCGGTAGG
V D L R E T Y Q A L I E I Q R H P
3410 3420 3430 3440 3450
AGATTATAGTCGGACAGATTTTCAGGTATTACTTAGTAAACTCAATCGTG
TCTAATATCAGCCTGTCTAAAAGTCCATAATGAATCATTTGAGTTAGCAC
D Y S R T D F Q V L L S K L N R
3460 3470 3480 3490 3500
ACTATGATCGGTTTGTAAGCCAATTTGGATACTTGAATGTCTCAGTCAAT
TGATACTAGCCAAACATTCGGTTAAACCTATGAACTTACAGAGTCAGTTA
D Y D R F V S Q F G Y L N V S V N
3510 3520 3530 3540 3550
CGAAACTTATTTGATAGTGACGATAAGTATTCTTTACTAGCAAGTTTAGA
GCTTTGAATAAACTATCACTGCTATTCATAAGAAATGATCGTTCAAATCT
R N L F D S D D K Y S L L A S L E
3560 3570 3580 3590 3600
AGATGAATACATTGATTCTAAAGATCAGAAAGTAAAATATAAAAAATCTT
TCTACTTATGTAACTAAGATTTCTAGTCTTTCATTTTATATTTTTTAGAA
D E Y I D S K D Q K V K Y K K S




L A F E K A L V R P E R V I T R V
3660 3670 3680 3690 3700
TCAACGGCTTTAGATGCCTTAAACTCCAGTTTATCAGATGGTAGAGGGGT
AGTTGCCGAAATCTACGGAATTTGAGGTCAAATAGTCTACCATCTCCCCA
S T A L D A L N S S L S D G R G V
3710 3720 3730 3740 3750
TGATATAGACTTTATGGTATCAATTTACCCTGAACATAGCCAAGCAGCTA
ACTATATCTGAAATACCATAGTTAAATGGGACTTGTATCGGTTCGTCGAT
D I D F M V S I Y P E H S Q A A
3760 3770 3780 3790 3800
TTTTAGATGAGTTGGGTGACCAGATCTTAATGGATCCAGAAAGCTATTTA
AAAATCTACTCAACCCACTGGTCTAGAATTACCTAGGTCTTTCGATAAAT
I L D E L G D Q I L M D P E S Y L
3810 3820 3830 3840 3850
AGAGGGGAAAGAAATTATCTTTCTAAGAACCAGTTTTTGTCAGGAGATAT
TCTCCCCTTTCTTTAATAGAAAGATTCTTGGTCAAAAACAGTCCTCTATA
R G E R N Y L S K N Q F L S G D I
3860 3870 3880 3890 3900
TCTCAACAAGATAGAAGTAGTTCAACTATTAGTAGAGGAAAACAACCAAG
AGAGTTGTTCTATCTTCATCAAGTTGATAATCATCTCCTTTTGTTGGTTC
L N K I E V V Q L L V E E N N Q
3910 3920 3930 3940 3950
AATGTGATTGGACTCATGCGTTAGATTTGTTAGAATCTGTTCGCCCTCCA
TTACACTAACCTGAGTACGCAATCTAAACAATCTTAGACAAGCGGGAGGT
E C D W T H A L D L L E S V R P P
3960 3970 3980 3990 4000
AGGATTCATCTGGCAGATATTGAGTTTAAAATAGGGTCACGTTGGATTCC
TCCTAAGTAGACCGTCTATAACTCAAATTTTATCCCAGTGCAACCTAAGG
R I H L A D I E F K I G S R W I P
4010 4020 4030 4040 4050
TCAATCCGTTTATGGTAAATTTGCCTTTGAATGTTTTACCAACCGTGAAT
AGTTAGGCAAATACCATTTAAACGGAAACTTACAAAATGGTTGGCACTTA
Q S V Y G K F A F E C F T N R E
4060 4070 4080 4090 4100
TTGAATTGTCTTCGCCTGATGTTGAACAAGTCATTGAAGTGAATCCTGTC
AACTTAACAGAAGCGGACTACAACTTGTTCAGTAACTTCACTTAGGACAG
F E L S S P D V E Q V I E V N P V
4110 4120 4130 4140 4150
GATGGGCAGGTTCATTTAAGGACACCATTTGCTTATCGCTATCCAAGTGC
CTACCCGTCCAAGTAAATTCCTGTGGTAAACGAATAGCGATAGGTTCACG
D G Q V H L R T P F A Y R Y P S A




K D S S L G V S G S R Y D T G R
4210 4220 4230 4240 4250
AGATTTTTGAGAATTTACTTAATTCGAACCAACCGACTATTACTATGACT
TCTAAAAACTCTTAAATGAATTAAGCTTGGTTGGCTGATAATGATACTGA
K I F E N L L N S N Q P T I T M T
4260 4270 4280 4290 4300
GTTACGGAAGGGGAAAAGAAAAAGACCATCACAGATTTGGAAAAAACCTC
CAATGCCTTCCCCTTTTCTTTTTCTGGTAGTGTCTAAACCTTTTTTGGAG
V T E G E K K K T I T D L E K T S
4310 4320 4330 4340 4350
TGTTCTAAGAGCAAAAGAGCAGCATTTACAAGAACTCTTTCAAGACTTTG
ACAAGATTCTCGTTTTCTCGTCGTAAATGTTCTTGAGAAAGTTCTGAAAC
V L R A K E Q H L Q E L F Q D F
4360 4370 4380 4390 4400
TCTCACGGTATCCAGAAGTTCAACAAGTCATTGAAGAAAGTTATAATCGT
AGAGTGCCATAGGTCTTCAAGTTGTTCAGTAACTTCTTTCAATATTAGCA
V S R Y P E V Q Q V I E E S Y N R
4410 4420 4430 4440 4450
CTTTATAATCGAACGGTTAGTCGAGAGTATGACGGTAGCCATTTAGTCAT
GAAATATTAGCTTGCCAATCAGCTCTCATACTGCCATCGGTAAATCAGTA
L Y N R T V S R E Y D G S H L V I
4460 4470 4480 4490 4500
TGATGGCTTGGCACAAAACATCAGTCTTCGTCCTCATCAAGAGAATGCCA
ACTACCGAACCGTGTTTTGTAGTCAGAAGCAGGAGTAGTTCTCTTACGGT
D G L A Q N I S L R P H Q E N A
4510 4520 4530 4540 4550
TTCAAAGAATTGTAGAAGAAAAAAGAGCCTTGTTAGCTCATGAGGTAGGT
AAGTTTCTTAACATCTTCTTTTTTCTCGGAACAATCGAGTACTCCATCCA
I Q R I V E E K R A L L A H E V G
4560 4570 4580 4590 4600
TCAGGAAAGACCTTGACCATGCTTGGTGCTGGCTTTAAATTAAAGGAGTT
AGTCCTTTCTGGAACTGGTACGAACCACGACCGAAATTTAATTTCCTCAA
S G K T L T M L G A G F K L K E L
4610 4620 4630 4640 4650
GGGGATGGTTCATAAGCCCTTGTATGTGGTGCCCTCTAGTTTGTCTGCTC
CCCCTACCAAGTATTCGGGAACATACACCACGGGAGATCAAACAGACGAG
G M V H K P L Y V V P S S L S A
4660 4670 4680 4690 4700
AGTTTGGCCAAGAAATCATGAAATTTTTCCCTACTAAAAAAGTCTTTGTG
TCAAACCGGTTCTTTAGTACTTTAAAAAGGGATGATTTTTTCAGAAACAC
Q F G Q E I M K F F P T K K V F V
55
4710 4720 4730 4740 4750
ACCACTAAGAAAGATTTTGTGAAGGCAAGAAGAAAACAGTTTGTGTCACG
TGGTGATTCTTTCTAAAACACTTCCGTTCTTCTTTTGTCAAACACAGTGC
T T K K D F V K A R R K Q F V S R
4760 4770 4780 4790 4800
TATTATTACAGGAGATTACGATGCCATTGTCATTGGGGATTCTCAATTTG
ATAATAATGTCCTCTAATGCTACGGTAACAGTAACCCCTAAGAGTTAAAC
I I T G D Y D A I V I G D S Q F
4810 4820 4830 4840 4850
AAAAAATCCCTGTCAGTAAGGAAAGACAGATGAATTATATCGAGGATAAA
TTTTTTAGGGACAGTCATTCCTTTCTGTCTACTTAATATAGCTCCTATTT
E K I P V S K E R Q M N Y I E D K
4860 4870 4880 4890 4900
CTCAATGAACTACGAGAGATTAAAACACATTCTGAAAATAAGTACACCGT
GAGTTACTTGATGCTCTCTAATTTTGTGTAAGACTTTTATTCATGTGGCA
L N E L R E I K T H S E N K Y T V
4910 4920 4930 4940 4950
TAAAGAAGCAGAGCAATCAATAAGTGGTCTTGAGAAACAATTGGAAGAAC
ATTTCTTCGTCTCGTTAGTTATTCACCAGAACTCTTTGTTAACCTTCTTG
K E A E Q S I S G L E K Q L E E
4960 4970 4980 4990 5000
TCCAACGCTTTAATCGTGATAGTTTTATTGATTTTGAGAACTTAGGAATT
AGGTTGCGAAATTAGCACTATCAAAATAACTAAAACTCTTGAATCCTTAA
L Q R F N R D S F I D F E N L G I
5010 5020 5030 5040 5050
GATTTTCTCTTTGTGGATGAAGCACATCACTTTAAAAATATACGTCCAAT
CTAAAAGAGAAACACCTACTTCGTGTAGTGAAATTTTTATATGCAGGTTA
D F L F V D E A H H F K N I R P I
5060 5070 5080 5090 5100
TACTGGACTTGGAAATGTAGCAGGGATTACCAATACAACGTCTAAGAAGA
ATGACCTGAACCTTTACATCGTCCCTAATGGTTATGTTGCAGATTCTTCT
T G L G N V A G I T N T T S K K
5110 5120 5130 5140 5150
ATGTGGATATGGAAATGAAGGTTCGACAGATTCAGGAAGAACATGATTTT
TACACCTATACCTTTACTTCCAAGCTGTCTAAGTCCTTCTTGTACTAAAA
N V D M E M K V R Q I Q E E H D F
5160 5170 5180 5190 5200
AAAAATATTGTCTTTGCGACAGGAACACCTGTTTCAAATTCAATTAGTGA
TTTTTATAACAGAAACGCTGTCCTTGTGGACAAAGTTTAAGTTAATCACT
K N I V F A T G T P V S N S I S E




L Y T M M N Y I Q P D I L K R Y
5260 5270 5280 5290 5300
AAGTTGATTATTTTGACTCTTGGGTAGGTGCTTTTGGAGAAATTCAAAAC
TTCAACTAATAAAACTGAGAACCCATCCACGAAAACCTCTTTAAGTTTTG
Q V D Y F D S W V G A F G E I Q N
5310 5320 5330 5340 5350
TCTATGGAATTAGCTCCTACAGGGGATAAGTACCAGCCTAAGAAACGATT
AGATACCTTAATCGAGGATGTCCCCTATTCATGGTCGGATTCTTTGCTAA
S M E L A P T G D K Y Q P K K R F
5360 5370 5380 5390 5400
TAAAAAGTTTGTCAATCTACCTGAGTTGATGAAAATCTATAAAGAAACAG
ATTTTTCAAACAGTTAGATGGACTCAACTACTTTTAGATATTTCTTTGTC
K K F V N L P E L M K I Y K E T
5410 5420 5430 5440 5450
CCGACATTCAAACACAAGATATGTTGGATTTACCTGTACCAGAAGCCCAT
GGCTGTAAGTTTGTGTTCTATACAACCTAAATGGACATGGTCTTCGGGTA
A D I Q T Q D M L D L P V P E A H
5460 5470 5480 5490 5500
ATTATCCCTATTGAGAGTGAGTTAACTGAAAACCAGAAACTCTATCTAGA
TAATAGGGATAACTCTCACTCAATTGACTTTTGGTCTTTGAGATAGATCT
I I P I E S E L T E N Q K L Y L E
5510 5520 5530 5540 5550
AGAATTGGTTATGAGATCAGATGCGGTCAAATGTGGAACAGTTGATCCAA
TCTTAACCAATACTCTAGTCTACGCCAGTTTACACCTTGTCAACTAGGTT
E L V M R S D A V K C G T V D P
5560 5570 5580 5590 5600
GTCAGGATAACATGTTAAAAATTACGGGTGAGGCACGAAAATTAGCTATT
CAGTCCTATTGTACAATTTTTAATGCCCACTCCGTGCTTTTAATCGATAA
S Q D N M L K I T G E A R K L A I
5610 5620 5630 5640 5650
GATATGCGTTTATTGGACTCTAGTTATAGTCTAGCAGACAATCATAAACT
CTATACGCAAATAACCTGAGATCAATATCAGATCGTCTGTTAGTATTTGA
D M R L L D S S Y S L A D N H K L
5660 5670 5680 5690 5700
GCTTCAGGTAGTGGATAATGTTGAAAGAATTTATCGTGAGGGAATGGAAA
CGAAGTCCATCACCTATTACAACTTTCTTAAATAGCACTCCCTTACCTTT
L Q V V D N V E R I Y R E G M E
5710 5720 5730 5740 5750
ATAAGGCTACTCAGATGATTTTTTCAGATATTGGCACACCTAAGAAAAAA
TATTCCGATGAGTCTACTAAAAAAGTCTATAACCGTGTGGATTCTTTTTT
N K A T Q M I F S D I G T P K K K
57
5760 5770 5780 5790 5800
GATAATGGCTTTGATGTTTATTCTGAGATTAAGGCTTTATTAGTTGATAG
CTATTACCGAAACTACAAATAAGACTCTAATTCCGAAATAATCAACTATC
D N G F D V Y S E I K A L L V D R
5810 5820 5830 5840 5850
AGGAATCCCTAGTATGGAAATTGCCTTTGTACATGATGCCAATAGTGATG
TCCTTAGGGATCATACCTTTAACGGAAACATGTACTACGGTTATCACTAC
G I P S M E I A F V H D A N S D
5860 5870 5880 5890 5900
AAAAGAAGAATAGCTTGTCTCGAAAGGTTAATGCAGGAGAGGTTCGGGTT
TTTTCTTCTTATCGAACAGAGCTTTCCAATTACGTCCTCTCCAAGCCCAA
E K K N S L S R K V N A G E V R V
5910 5920 5930 5940 5950
CTTCTTGCCTCAACTGAAAAAGGAGGAACAGGTTTAAATGTTCAGAGCAA
GAAGAACGGAGTTGACTTTTTCCTCCTTGTCCAAATTTACAAGTCTCGTT
L L A S T E K G G T G L N V Q S K
5960 5970 5980 5990 6000
GATGAAAGCAGTTCACCATCTGGATGTACCGTGGAGACCAAGTGACATTC
CTACTTTCGTCAAGTGGTAGACCTACATGGCACCTCTGGTTCACTGTAAG
M K A V H H L D V P W R P S D I
6010 6020 6030 6040 6050
AGCAACGTAATGGACGTATTATCCGACAGGGAAATGAAAACAAGGAAGTG
TCGTTGCATTACCTGCATAATAGGCTGTCCCTTTACTTTTGTTCCTTCAC
Q Q R N G R I I R Q G N E N K E V
6060 6070 6080 6090 6100
GATATTTACCACTATATTACCAAAGGTTCGTTTGATAATTATCTATGGGC
CTATAAATGGTGATATAATGGTTTCCAAGCAAACTATTAATAGATACCCG
D I Y H Y I T K G S F D N Y L W A
6110 6120 6130 6140 6150
AACTCAGGAGAACAAACTCCGTTATATTAAGCAGATTATGACTTCTAAGG
TTGAGTCCTCTTGTTTGAGGCAATATAATTCGTCTAATACTGAAGATTCC
T Q E N K L R Y I K Q I M T S K
6160 6170 6180 6190 6200
AGCCGATTCGTGCTGCGGAAGATATTGATGAACAGACTATGACAGCTTCT
TCGGCTAAGCACGACGCCTTCTATAACTACTTGTCTGATACTGTCGAAGA
E P I R A A E D I D E Q T M T A S
6210 6220 6230 6240 6250
GATTTTAAGGCACTAGCAACAGGTAATCCTTATCTCAAATATAAGATGGA
CTAAAATTCCGTGATCGTTGTCCATTAGGAATAGAGTTTATATTCTACCT
D F K A L A T G N P Y L K Y K M E




L E N D L T L L E N Q R R A F Q
6310 6320 6330 6340 6350
GCAGCAAGGATCACTATCGTCATACAATCTCTTACTGTGAAGAAAATATG
CGTCGTTCCTAGTGATAGCAGTATGTTAGAGAATGACACTTCTTTTATAC
R S K D H Y R H T I S Y C E E N M
6360 6370 6380 6390 6400
CCCATTCTTGAGAAACGATTAAGCAAGTATGAAGGCGACATTCAACAGTC
GGGTAAGAACTCTTTGCTAATTCGTTCATACTTCCGCTGTAAGTTGTCAG
P I L E K R L S K Y E G D I Q Q S
6410 6420 6430 6440 6450
TGAAATGTCGAAAGACCAATCATTTTCTATGACGATAGGTAAACAAGTTT
ACTTTACAGCTTTCTGGTTAGTAAAAGATACTGCTATCCATTTGTTCAAA
E M S K D Q S F S M T I G K Q V
6460 6470 6480 6490 6500
TTGAGCAACGAGCTGAAGCAGGTGAATCCCTACACCGTCTTATCCGTCAT
AACTCGTTGCTCGACTTCGTCCACTTAGGGATGTGGCAGAATAGGCAGTA
F E Q R A E A G E S L H R L I R H
6510 6520 6530 6540 6550
AATCAATCTGACAGCAAAGAATTTCGAACCCTAGCAAGTTATCGAGGATT
TTAGTTAGACTGTCGTTTCTTAAAGCTTGGGATCGTTCAATAGCTCCTAA
N Q S D S K E F R T L A S Y R G F
6560 6570 6580 6590 6600
TGACATTAAAATGCTTAGTCTTGCAACAAATCAACCTCTTCCTGAAACCT
ACTGTAATTTTACGAATCAGAACGTTGTTTAGTTGGAGAAGGACTTTGGA
D I K M L S L A T N Q P L P E T
6610 6620 6630 6640 6650
TCTCTGTTAAGATTGTAGGAGAAAACCAATATTCTGTCAGTTTAGATTTG
AGAGACAATTCTAACATCCTCTTTTGGTTATAAGACAGTCAAATCTAAAC
F S V K I V G E N Q Y S V S L D L
6660 6670 6680 6690 6700
TATTCTCCTTTGGGGACAATTCAAAGGCTTCAGCATACGATAGACCACAT
ATAAGAGGAAACCCCTGTTAAGTTTCCGAAGTCGTATGCTATCTGGTGTA
Y S P L G T I Q R L Q H T I D H I
6710 6720 6730 6740 6750
TAAAGATGACCAAGTGAAAACTCAGAACTTATTGGATGAATTAAAGGATA
ATTTCTACTGGTTCACTTTTGAGTCTTGAATAACCTACTTAATTTCCTAT
K D D Q V K T Q N L L D E L K D
6760 6770 6780 6790 6800
AATGGACTACTGCTAAGGTAGAAATTGAGAAAAATTTTCCAAAGGAAGAG
TTACCTGATGACGATTCCATCTTTAACTCTTTTTAAAAGGTTTCCTTCTC
K W T T A K V E I E K N F P K E E
59
6810 6820 6830 6840 6850
GATTATCAAACTAAAAAGGCCGAATACGATGTACTCGCGCCATTGATTGA
CTAATAGTTTGATTTTTCCGGCTTATGCTACATGAGCGCGGTAACTAACT
D Y Q T K K A E Y D V L A P L I E
6860 6870 6880 6890 6900
AACAGAAACGGATTTAGATATTATTGATCAGGCCTTACGACAATTCCACG
TTGTCTTTGCCTAAATCTATAATAACTAGTCCGGAATGCTGTTAAGGTGC
T E T D L D I I D Q A L R Q F H
6910 6920 6930 6940 6950
AAAAAGGAAAAGAAAAGCAAGAACAACTTTCTTTTGAATTAGATTAAAAA ORF2
TTTTTCCTTTTCTTTTCGTTCTTGTTGAAAGAAAACTTAATCTAATTTTT
E K G K E K Q E Q L S F E L D *
6960 6970 6980 6990 7000
ATAGATATAAATAGCGGACAAGAAAAGAAAAGCGCGGTAGMATAAAGATA
TATCTATATTTATCGCCTGTTCTTTTCTTTTCGCGCCATCKTATTTCTAT
7010 7020 7030 7040 7050
GAAAGAAACGAGGTAACGATTATGATGGAAGATACCTATTATCAATTAGA
CTTTCTTTGCTCCATTGCTAATACTACCTTCTATGGATAATAGTTAATCT
M E D T Y Y Q L E
7060 7070 7080 7090 7100 ORF3
AGAGGCTTTGGTACAGGGATTTCAAACACCTGAAGAATACCAAGCCTACA
TCTCCGAAACCATGTCCCTAAAGTTTGTGGACTTCTTATGGTTCGGATGT
E A L V Q G F Q T P E E Y Q A Y
7110 7120 7130 7140 7150
AGGAGTTAAAGGAACATTATGAGGAAGTGACAGGGGATTACAGTTTTTCT
TCCTCAATTTCCTTGTAATACTCCTTCACTGTCCCCTAATGTCAAAAAGA
K E L K E H Y E E V T G D Y S F S
7160 7170 7180 7190 7200
AAACGAGAGCTCACTAGTCAATTGGAAATCGCTCTTCAGAATCATCAAGG
TTTGCTCTCGAGTGATCAGTTAACCTTTAGCGAGAAGTCTTAGTAGTTCC
K R E L T S Q L E I A L Q N H Q G
7210 7220 7230 7240 7250
TGTGGACTTTGAAGAACATGAAAAAGAAGAGTATTTGGACTTAGTTCAAA
ACACCTGAAACTTCTTGTACTTTTTCTTCTCATAAACCTGAATCAAGTTT
V D F E E H E K E E Y L D L V Q
7260 7270 7280 7290 7300
AATTAGAAGAGTTTGATTCCTCTCTTGCCACCCATTATCGTCAGTTGATT
TTAATCTTCTCAAACTAAGGAGAGAACGGTGGGTAATAGCAGTCAACTAA
K L E E F D S S L A T H Y R Q L I





M N D L L L I P V I
7360 7370 7380 7390 7400 ORF4
TTTTAGCAGTAGGAGGAATTATCATTCTTTTATGGAGACTCTTTCTTATT
AAAATCGTCATCCTCCTTAATAGTAAGAAAATACCTCTGAGAAAGAATAA
F L A V G G I I I L L W R L F L I
7410 7420 7430 7440 7450
GCCAGTGGACTTTTCCTTATTGGTTTTGTCAGTTTTCTTATTTTCGTAGA
CGGTCACCTGAAAAGGAATAACCAAAACAGTCAAAAGAATAAAAGCATCT
A S G L F L I G F V S F L I F V E
7460 7470 7480 7490 7500
GGTCTATGGAATTTATCTGTTCTTTACTGAACCTAGTTTATATTTTGATG
CCAGATACCTTAAATAGACAAGAAATGACTTGGATCAAATATAAAACTAC
V Y G I Y L F F T E P S L Y F D
7510 7520 7530 7540 7550
ATATCAGACAATATGGTTTAACTAGTTTTACGGCTGTGTACCTTTTCATC
TATAGTCTGTTATACCAAATTGATCAAAATGCCGACACATGGAAAAGTAG
D I R Q Y G L T S F T A V Y L F I
7560 7570 7580 7590 7600
AATCTGATGTTGGTTCTAGGATTTAGTTGGCGCTTCATTAACTCCATAAA
TTAGACTACAACCAAGATCCTAAATCAACCGCGAAGTAATTGAGGTATTT
N L M L V L G F S W R F I N S I N
7610 7620 7630 7640 7650 ORF4
TAAGCATAAAATGTGAACTTTTTAGATAGTTAAAAGACTTTATTCAAAGG
ATTCGTATTTTACACTTGAAAAATCTATCAATTTTCTGAAATAAGTTTCC
K H K M *
7660 7670 7680 7690 7700
TAAGTTTGAATAAAGTCTTTTTGTTGATGTGCTTATAATCCCGTCTTAGT
ATTCAAACTTATTTCAGAAAAACAACTACACGAATATTAGGGCAGAATCA
7710 7720 7730 7740 7750
ACTTAGTGTGAGAAACAAAAAGAGATGAATTAAAATTAAAGTGTACAGAA
TGAATCACACTCTTTGTTTTTCTCTACTTAATTTTAATTTCACATGTCTT
7760 7770 7780 7790 7800
TGCTTAAGAGTTTCTATTTTTCTTATAATATATAGTAATTTCGGTACAAA
ACGAATTCTCAAAGATAAAAAGAATATTATATATCATTAAAGCCATGTTT




V583, Bucepa 03001966 from Burkholderia cepacia R1808, and cpp14 from
Campylobacter jejuni. Most of these sequences listed are found associated with either
plasmids or transposons.
Analysis of the deduced amino acid sequence of ORF2 showed the presence of
two conserved domains, one for a helicase and one for a methylase (Fig. 3). Besides these
two conserved domains, there was also a set of motifs which are usually found in the
protein of the DEAD-box helicase family proteins. In Fig 4, the common sub-groups of
helicases belonging to the DEAD-box helicase family are shown. By comparing the
amino acid sequence between the residues 1278 and 1773, which contains the conserved
motifs of DEAD-box helicase family (Fig. 4, ORF2 was found to belong to the DEAH*
sub-group (NH2--G-GKT---DEAH----A-------GR-----COOH) which contain an ATP-
biding motif (I), ATP-hydrolysis/nuclic acid-unwinding motif (II and III), and a nuclic
acid binding motif (VI). The Ia, Ib, and V motifs found in protein of the DEAD-box
helicase family were missing in ORF2 [93, 94]. DEAH* subgroup of proteins, such as the
RAD3 of Sacchromyces cerevisiae and Eco KI HsdR of E. coli are DNA, rather than
RNA, helicases [95]. The predicted structure of the ORF2 protein suggests that ORF2
could be a DNA helicase. However, experimental evidence to support this hypothesis is
not available yet.
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Introduction of the helicase operon into clinical pneumococci
To determine the function of the helicase operon during pneumococcal
pathogenesis, we sought to introduce the operon from the non-encapsulated avirulent
laboratory strain into a clinical encapsulated strain. However, filter mating, the traditional
method for conjugation, was not able to create sufficient surface contact between the non-
encapsulated strain and the encapsulated strain. Hence, the helicase operon was
introduced into clinical strains by transformation as described below. This was
accomplished by using an E.coli recombinant plasmid carrying the entire operon with
surrounding transposon DNA.
Creation of Plasmid pSS141
Plasmid pSS141 was created previously as shown in Fig. 5 [5]. Briefly, an E.coli
vector plasmid, pVA891 which does not autonomously replicate in streptococci, was
inserted in the orientation shown in Fig. 5 into a pneumococcal lab strain with Tn5252 ∆
cat. The chromosomal DNA was digested with KpnI followed by a self-ligation. The self-
ligated DNA was used to transform E.coli to obtain the plasmid, pSS141, carrying a 28
kb passenger DNA derived from coordinates 4.1 to 32.1 of Tn5252∆ cat.
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Fig 3. P-fam search on deduced amino acid sequence from ORF2. There are two
conserved domains identified, the methylase domain, with e-value of 1.8*10-5 and
DEAD-Box helicase domain with e-value of 6.2*10-5.
Methylase Domain DEAD-Box Helicase Domain
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Organization and conserved motifs in
DEAD-box family of helicases
Fig 4. Conserved motifs in DEAD-box family of helicase [93]. There are 4 sub-groups in
DEAD-box protein family. The DNA helicases belong to the DEAH* subgroup which
lack the motifs, Ia, Ib and V.
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Fig. 5. Structure and partial restriction endonuclease map of the E. coli plasmid pSS141.
(A) Tn5252∆cat; (B) passenger DNA in pSS141; and (C) the E. coli vector plasmid
pVA891. The location of the IS-like sequence and the ends of the element, attL and attR,
are indicated. Relevant restriction sites are shown. Spontaneous curing of the 8 kb DNA
carrying the chloramphenicol resistance determinant flanked by two directly repeated
copies of the IS-like sequence, due to homologous recombination, led to the isolation of
SP1403. The cryptic conjugative transposon, Tn5252∆cat, in SP1403 carries a single
copy of the IS- like sequence. BamHI-digested pVA891 was inserted at the BglII site
within the Tn5252∆cat as shown in panel B. The chromosomal DNA from an Emr
transformant was digested with KpnI, self-ligated, and used to transform E. coli. The
resulting recombinant plasmid was designanted pSS141. The shaded arrows in panel B
show the location and orientation of the four open reading frames in the helicase operon.
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Creation of clinical pneumococcal strains for virulence assay
For convenience in the virulence assays, a genetic marker, str, was introduced
into clinical wild type D39 (serotype II) and WU2 (serotype III) by transforming D39 and
WU2 with DP1617 DNA and selecting for streptomycin resistance. D39 with str was
named SP3001 and WU2 with the str was named SP3101. Similarly, SP3003 and SP3100
were obtained by introducing the nov marker into D39 and WU2.
Creation of clinical pneumococcal strains with the helicase operon
Introduction of the helicase operon into clinical strains was achieved by using
pSS141 as donor DNA to transform SP3001 and SP3101. Plasmid vector, pVA891 [86],
is not able to autonomously replicate in streptococci. This plasmid carries
chloremphenicol and erythromycin resistance, but only erythromycin resistance is
expressed in streptococci. In pSS141, there is an IS-like sequence, derived from Tn5252.
We presumed that the chromosome of most pneumococci carried this element. When
pSS141 was used as donor DNA to transform recipient clinical strains, as is shown in
Fig. 6, the only way that recipient cell could gain resistance to erythromycin was through
insertion of the entire pSS141 into the chromosome through insertion-duplication induced
by the homology between the IS-like sequence in pSS141 and in the chromosomal DNA
of clinical strains. As expected, pSS141 was successfully inserted into chromosomes of
SP3001 and SP3101 to create SP3004 and SP3102, respectively. To create an insertion-
mutation within the helicase operon, the plasmid, pZH12 was used. PZH12 was created
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Fig. 6. Insertion of pSS141 into chromosomal DNA of clinical strains. I. As hypothesized
and proved, the IS-likes sequence residing in pSS141 also resided in chromosome DNA
of clinical strain. II. When intact pSS141 was used as donor DNA to transform clinical
strain, the homology between IS-like sequence in pSS141 and IS-like sequence in
chromosomal DNA of clinical strain would induce insertion duplication, in a process of
which, entire pSS141 was inserted into chromosomal DNA of clinical strain, and IS like
sequence was duplicated.
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Fig. 7. Strategy for the creation of an insertion mutation in the helicase operon in
SP3004 and SP3102
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as shown in Fig. 7. Plasmid pDR18 consists of a 1.65 kb HindIII fragment of DNA from
ORF2 cloned into plasmid pSK+. To create plasmid pZH12, a cassette containing the Km
resistance gene, was obtained by BamHI digestion of pZH2 and was inserted into the
unique BglII site in pDR18. Plasmid pZH12 was linearized with PstI before it was used
to transform SP3004 and SP3102. As is shown in Fig. 7, the homology between the
sequence flanking the insertion cassette and the sequence in the host chromosome
facilitated the insertion of cassette with Km resistance gene into the helicase operon in
the bacterial chromosome, thus creating an insertion-mutation in the helicase operon. The
new created strains from SP3004 and SP3102 were designated SP3005 and SP3103,
respectively.
Southern hybridization to determine the integrity of inserted DNA in the
newly created strains
Chromosomal DNA from SP3001, SP3004, SP3005, SP3101, SP3102 and
SP3103 were isolated and analyzed in southern hybridization by using pSS141 as a probe
to determine if the constructs in the chromosome of these strains were the same as
expected (Fig. 8). Chromosomal DNAs from SP3001 and SP3101 showed hybridization
to pSS141, indicating that the IS like sequence was present in the chromosome DNAs of
SP3001 and SP3101 also. Since the genomic sequences of these two clinical strains were
not available, it was impossible to predict the exact size of each band. However, the
bands representing the helicase operon were not present in either SP3001 or SP3101,
which indicated that the helicase operon was not present in these two strains. Insertion of
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pSS141 into the recipient genome at the site of the IS-like element by insertion-
duplication was expected to yield EcoRI fragments of 9.1, 4.6, 4.3, 2.6, 2.1, 1.9, 0.9, and
0.6 kb, and HindIII fragments of 6.9, 4.6, 3.3, 2.7, 1.7, 1.0, 0.3, and 0.2 kb. Similarly,
insertion of the 5.3 kb lacZ-Kamr cassette within the 1.65 kb HindIII in ORF2 was
expected to additionally yield 9.2 and 5.2 kb EcoRI fragments and 5.2 and 1.8 kb HindIII
fragments in SP3005 and SP3103. The band patterns observed confirmed that SP3004,
SP3005, SP3102 and SP3103 each had the expected chromosomal structures. 
 
Virulence studies
Since the colony morphology of clinical pneumococcus has been correlated with
different capabilities to colonize various niches inside host[43], all strains to be used for
infection were examined for colony morphology type. All the strains were found to be of
the "transparent type” by the criteria described earlier.
To study the effect of the presence of the helicase operon in pneumococcal
virulence, dilutions of cultures of each of the three strains in the D39 background were
injected intraperitoneally into young female BALB/c mice. The mice were monitored at
12 hr intervals for four days to determine the mortality rate. As shown in Fig. 9, SP3004,
the strain bearing pSS141 in the chromosome, resulted in a significantly fewer deaths
than SP3001 (the parental strain) and SP3005 (the one with mutated helicase operon).
Strains SP3001 and SP3005 resulted in similar mortality rates. As shown in Fig 9, the
three strains in WU2 background also displayed similar results.
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Fig 8. Physical analysis of chromosomal DNA of S. pneumoniae clinical strains showing
the insertion of pSS141. Autoradiogram showing DNA-DNA hybridization of 32P-labeled
pSS141 to DNA from (a) SP3001, (b) SP3004, (c) SP3005, (d) SP3101, (e) SP3102, and
(f) SP3103. EcoRI digests are shown in I and HindIII digests are shown in II. Lanes m,
marker DNA containing linearized plasmids of known molecular weights that are
expected to react with the probe DNA.











For the pneumonia model, isoflurane-anesthetized mice were intranasally infected
with about 106 cfu (in 50 µl) of pneumococcal cells and monitored for four days (Fig.
10). When introduced into the nasopharyngeal region, SP3004 cell was able to cause
significantly more death than SP3001 or SP3005. Similarly, SP3102 cells, caused more
death than SP3101 or SP3103 when introduced by the nasal route (Fig 10). Even though
all the infected animals showed morphological signs of disease such as staring coat, the
mice nasally infected with strains carrying the intact operon succumbed more often than
those infected with the other two strains. Thus, the presence of the helicase operon
seemed to have an effect on the virulence of pneumococci depending on the route of
infection. These results suggest that the helicase operon is activated in vivo in both routes
of inoculation.
Competition Assays
To confirm the results obtained in the virulence assays, in vivo competition assays
using a mixture cells with and without a functional helicase operon were performed. For
intranasal challenge, a mixture of equal amounts of SP3003 (nov) and SP3004 (str) cells
were used for infection. As a control, to estimate the effect of the antibiotic resistance
markers used on bacterial fitness in vivo, mice were also separately infected with mixed
cultures containing approximately equal amounts of the parental strains, SP3001 (str) and
SP3003 (nov) [96]. During intranasal challenge, as is shown in Fig. 11, ultimately at 65
hours postinfection, SP3001 (a strr derivative of D39) demonstrated as 4 times more




















Fig. 9. Effect of the helicase operon on virulence of the indicated bacteria infected
through the intraperitoneal route (A) D39 derivates (B) WU2 derivatives. Mortality was
assessed periodically up to 72 hours post infection. The data presented in A is an average





































Fig 10. Effect of the helicase operon on virulence of the indicated bacteria infected
through the intranasal route (A) D39 derivates (B) WU2 derivatives. Mortality was
assessed periodically up to 72 hours post infection. The data presented in A is an average



















while SP3004 demonstrated as 20 times more efficiently than SP3003 in survival in the
same region. Similarly, as is shown in Fig. 12, the same trend was identified with WU2
derivatives, SP3102 and SP3100.
During intraperitoneal challenge, as shown in Table V, mixed infections of
SP3001 and SP3003 resulted in an 18-fold increase of SP3003 cells in comparison to
SP3001 cells at 24 hours post-infection. Mixed infection of SP3003 and SP3004 resulted
in 75-fold increase of SP3003 cells in comparison to SP3004 at 24 hours post-infection.
This competitive edge of SP3003 was decreased when co-infected with SP3005 carrying
an insertion mutation within ORF2 in the helicase operon. Similar results were obtained
in competition experiments with genetically different strains, SP3102 and SP3100, as is
shown in Fig. 13 which indicated a definitive role for the helicase operon in
pneumococcal intraperitoneal infection. These results were in support of the data
obtained from virulence assays in confirming that the presence of helicase operon
differentially modulated the virulence of these strains depending on the route of infection.
On the other hand, the competition edge of a given strain, observed in












Fig. 11. Competitive indices for SP3003 (wt, nov) mixed either with SP3001 (wt, str,
filled circles) or SP3004 (Ω helicase operon str, open squares) in nasopharyngeal
colonization assays. The data shown for the pair of strains are derived from competitive
infections of at least two mice. Error bars indicate standard deviations.
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Fig. 12. Competitive indices for SP3100 (wt, nov) mixed with SP3102 (Ω helicase
operon str) in nasopharyngeal colonization assays.








0 1 7 4 1 6 5
T im e (h o u rs )
S P 3 1 0 0 /S P 3 1 0 2
78
Study on induction of helicase operon
Insertion of reporter gene lacZ into ORF2 in helicase operon
For the purpose of inserting the lacZ reporter gene into the helicase operon, a fragment of
DNA containing the whole ORF1 and part of ORF2 was amplified by PCR using primer
G54-1 and G54-ORF1-F. Then the PCR fragment was then inserted into the SmalI site in
pEVP3 to create the E. coli plasmid, pZH38. The DNA sequence of the insert in the
recombinant plasmid was obtained using the primers flanking the SmalI site, pEVP3-F
and pEVP3-R. The DNA sequence information confirmed that the transcriptional
orientation of the inserted DNA was correct. The intact plasmid pZH38 was then used to
transform pneumococcal strain SP1403 to create a chloramphenicol resistance strain,
SP1472. SP1472 is the product of a transcriptional fusion of lacZ into ORF2 in the
helicase operon through insertion-duplication. In SP1472, lacZ is expected to be
transcribed and translated when transcription of operon becomes active.
Identification of conditions required for the induction of helicase operon
In order to determine the conditions required for the induction of the helicase
operon, SP1472 was plated out in a chemical defined medium with X-gal. As shown in
Table VI, colonies growing on agar plates supplemented with 50 µM Fe2+ turned blue
after 72 hours of growth. Other divalent cations such as 50 µM Mn2+, 50 µM Zn2+, 50 µM
MgCl, and 50 µM CaCl2 or 0.1 M NaCl did not result in the activation of the operon and





















Fig. 13. Competitive indices for SP3100 (wt, nov) mixed either SP3102 in vivo and
inoculated by intraperitoneal inoculation. Samples were collected at 0 and 24 hours post-
infection.
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TABLE V. Competitive indices for SP3003 (wt, nov) mixed with SP3001, SP3004 or





SP3003 + SP3001 In vitro 0.67 ± 0.25
In vivo 18.52 ± 2.95
SP3003 + SP3004 In vitro 1.35 ± 0.13
In vivo 74.41 ± 15
SP3003 + SP3005 In vitro 0.33 ± 0.1
In vivo 21 ± 2.82
aData are the means ± standard deviations from two intraperitoneally infected mice or
two independent mixed cultures grown in vitro.
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concentration on the induction of the helicase operon, SP1472 was plated out in a
chemical defined agar with X-gal and different concentrations of Fe2+. It was found that
at least 5 µM of Fe2+ can weakly induce the expression of the helicase operon. However,
when SP1472 was grown in chemicaly defined broth, 5 µM Fe2+ led to no significant
increase in β-gal Miller units. These results indicated that Fe2+ was only one of the
factors required for induction of the helicase operon.
Effect of ORF1 on Induction of Helicase Operon
Since it was predicted that there was a calcium binding motif in ORF1 product,
and transcription of the helicase operon was slightly induced by 5 µM Fe2+, it was
suspected that ORF1 may be involved in transcriptional regulation of the helicase operon.
To determine the effect of ORF1 in transcriptional regulation of the helicase operon, the
promoter region and promoter with ORF1 were each cloned separately into an E.coli-
pneumococcus shuttle vector, pTCV-lac.
Creation of pZH48 and pZH49
The strategy used to create pZH48 and pZH49 is shown in Fig 14. Briefly, the
promoter region of the helicase operon was amplified using primers VK109 and PmR-
G54-orf1. The PCR product was cloned into the SmalI site in pSK+. By sequencing, the
orientation of the inserted the PCR product was determined. As shown in Fig 14, the
clone picked contained a unique PstI site in the vector portion upstream of the helicase
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Table VI. Effect of divalent cation on induction of the helicase operon. Strain SP1472
was plated in chemically defined agar medium supplemented with X-gal in presence of
the various cations listed below.
Condition tried Color of Colonies a
50 µM Mn2+ White
50 µM Zn2+ White
50 µM MgCl2 White
50 µM CaCl2 White
0.1 M NaCl White
50 µM Fe2+ Blue
a. Colony color was observed after 72 hours.
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operon promoter and this vector designated pZH46. Similarly, sequence containing the
promoter region of the helicase operon and ORF1 was amplified using primers VK109
and G54-1 and the PCR product was inserted into the SmalI site in pSK+. After
determination of the orientation of the insert by sequencing, a clone was picked and
named pZH47. By inserting a spectinomycin resistance cassette, predigested by PstI, into
the unique PstI site of pZH46 and pZH47, pZH48 and pZH49 were created.
Creation of pVJ603 and pVJ604 and Assay of SP1516 and SP1517
The E.coRI-BamHI fragment from pZH48 and pZH49 was purified and inserted
into pTCV-lac, which was digested with E.coRI and BamHI, to create pVJ604 and
pVJ605, respectively. Plasmids pVJ603 and pVJ604 were then used to transform
pneumococcal β-gal- strain CP1250 to create SP1516 and SP1517, respectively. When
SP1516 and SP1517 were plated in a chemically defined medium with 5 µM Fe2+ and X-
gal, colonies from both turned blue after 72 hours. However, when they were grown in
chemically defined medium with 50µmol Fe2+ supplement, no β-gal Miller unit was
obtained from either of them. These results indicated that ORF1 in the helicase operon
was unlikely to be involved in regulating of the helicase operon.
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Fig. 14-a. Strategy for the creation of pVJ604
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Fig. 14-b Strategy for the creation of pVJ605
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Creation of a pneumococcus strain with the helicase operon
controlled by the inducible promoter PmalX
Analysis of the deduced amino acid sequence from the helicase operon and
predicted cytoplasmic localization of ORF1, ORF2 and ORF3 implied that the protein
products of these three open reading frames could be involved in regulation of other
virulence related genes. Limited understanding on the induction of this operon made it
difficult to directly study the function of this operon. In order to solve this problem, it
was useful to insert an inducible promoter in between the natural promoter and ORF1. It
was reported that transcription driven by the maltose promoter, Pmalx, was regulated by
maltose [97]. So in our study, we inserted the maltose promoter Pmalx upstream of ORF1
in the helicase operon, so that the expression of this operon would be activated by
maltose supplemented in medium.
Creation of SP1407
Dr Vijayakumar amplified the gene encoding the maltose repressor, malR, from
chromosomal DNA using primers MalR-F and MalR-R. The PCR product was digested
with EcoRI and inserted into the E.coRI site in pLS1. This plasmid was named pVJ572.
Plasmid pVJ572 was then used as donor DNA to transform SP1403, a pneumococcal β-
gal- strain. The new strain was named SP1407
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Creation of pVJ595
To make it convenient in later transformations, a construct, in which MalX
promoter was tagged with an antibiotic resistance gene, was created as shown in Fig. 15.
The MalX promoter from chromosomal DNA was amplified using primers Pm-Mal3 and
Pm-Mal4. The PCR product was inserted into the SmalI site in pDL278-D. The new
plasmid was named pVJ587. An erythromycin resistance cassette, obtained from pDG647
digested with HindIII, was then inserted into the HindIII site in pVJ588. The new plasmid
was designated as pVJ595.
Insertion of PmalX-Em
r upstream of the helicase operon by crossover PCR
For crossover PCR, as shown in Fig 16, the PmalX-Em
r cassette was amplified
from pVJ595 by using the primers, 647 Em-F and Pm-Mal3. A piece of DNA upstream
of the insertion site was amplified from chromosomal DNA by using primers VK107 and
VK108. Also, a piece of DNA downstream of insertion site was amplified from
chromosomal DNA using the primers G54-1 and VK110. In VK110, there were 17 bases
in the 5’ end complementary to 3’-end of the malX promoter. Similarly, in VK107, there
were 17 bases at the 5’ end that were complementary to the 3’-end of the Em resistance
gene. In the second step, the three PCR products obtained in the first step were mixed
together and amplified by using the primers from the terminal ends, G54-1 and VK109,
to obtain one fragment of 3.5 kb containing of all three input DNAs. Then the large
fragment was purified and used as donor DNA to transform the pneumococcal strain
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Fig. 15. Strategy for the creation of pVJ595. In pVJ595, the malX promoter was tagged
with the antibiotic resistance gene, Emr, which provided a selection marker for
introduction of malX promoter into pneumococcus.
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SP1407. The newly created strain was named SP1460. To create a pneumococcal strain
with the inducible promoter malX in a strain without pVJ572, chromosomal DNA from
SP1460 was prepared and used as donor DNA to transform SP1403 to create the strain
SP1519.
Southern Hybridization to determine the insertion of malX Promoter
Chromosomal DNA from SP1460 and SP1000 were prepared and analyzed by Southern
hybridization was performed using the probe pZH22, in which a 6 kb SstI fragment from
the center region of Tn5252 was cloned into pAT29. Prior to the insertion of PmalX, the
helicase operon in Tn5252 is expected to have a 6.0 kb SstI fragment; 1.65 kb, 3.33 kb
and 3.59 kB HindIII fragment; 7.32 kb band BamHI fragment; 17.5 kb band EcoRI. With
the insertion of PmalX-Em cassette, the helicase operon in Tn5252 is expected to have 4.67
kb and 3.13 kb SstI fragments; 1.65 kb, 1.47 kb, 3.33 kb and 3.92 kb of HindIII
fragments; 3.6 kb, and 5.5 kb bands of BamHI fragments; and 6.25 kb and 12.52 kb of
EcoRI fragments. As shown in Fig. 17, the hybridization pattern of SP1460 DNA
indicated that the PmalX-Em cassette was inserted giving rise to the expected bands. The
patterns seen with SP1000 (negative control) and another clone, SP1437, indicated that
there was no malX-Em cassette inserted upstream of the helicase operon. Hence SP1460
was used in further experiments.
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Induction Assay on SP1474
Though results obtained from Southern hybridization proved that SP1460 was the
expected construct, to further confirm that the helicase operon in SP1460 will be induced
as expected, we introduced the transcriptional fusion, lacZ into ORF2 in the helicase
operon. Plasmid DNA pZH38 was used as donor DNA to transform SP1460, the strain
with helicase operon controlled by PmalX promoter. The new strain was named SP1474.
When SP1474 was plated out in CATPM (the same concentration of maltose substituted
for glucose as in CATPG) and X-gal, colonies gave a dark blue color on the second day.
Similar results were obtained when the reporter gene was inserted into strain SP1519.
Then SP1474 was grown in CATP with 1% (w/v) glucose, 1% (w/v) maltose, 2%
maltose, 4% maltose, 6% maltose and 8% maltose, respectively. Miller β-galactosidase
acitvity was measured in each sample. As shown in Table VII, SP1474 showed some
leaky expression when it was grown in glucose, in comparison to the negative control.
When it was grown in the same concentration of maltose, there was about 2.5 times
induction. However with the increase of maltose concentration, there was no significant
increase of β-gal activity.
Global Search for genes influenced by the helicase operon
Results from the induction assay of SP1474 confirmed that in strain SP1460,
expression of the helicase operon was induced as expected by maltose. To globally search
for genes potentially influenced by the helicase operon, the reporter gene lacZ was used
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to randomly mutagenize the chromosome of SP1460. The strategy employed is shown
Fig. 18. In brief, chromosomal DNA from CP1250 was prepared and digested with MboI.
The digested DNA was ligated into pEVP3 digested with BamHI. The ligation mixture
was used to transform E.coli competent cells and Cmr transformants were obtained. All
the colonies obtained were pooled together and used to prepare plasmids. The plasmid
pool was then used to transform the pneumococcal strain, SP1460. The transformants
were initially plated out on CATPG agar with X-gal. Then they were replicate-plated on
CATPG with X-gal and CATPM with X-gal to screen the clones which gave blue color
in CATPG but white color in CATPM or vice versa. Altogether, there were more than
5,000 clones screened, however, none of them appeared to give differential color
patterns.
Effect of the induction of the helicase operon on pneumococcal
survival during oxidative stress
The results from induction of the helicase operon show that Fe2+ is one of the
factors required for induction. It has been reported that during Fenton’s reaction, Fe2+ is
able to react with hydrogen peroxide, a by-product generated during pneumococcal
aerobic growth, to generate hydroxyl radicals which are harmful to pneumococcal cells
[98]. For this reason, it was suspected that induction of the helicase operon may have an
effect on pneumococcal survival in the presence of hydrogen peroxide
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Fig. 17. Southern hybridization analysis of the strains with the MalX promoter
inserted upstream of helicase operon. Autoradiogram showing DNA-DNA
hybridization of 32P-labeled pZH22 to DNA from (a) SP1460, (b) SP1437, and (c)
SP1000 digested by SstI (I), HindIII (II) EcoRI (III), and BamHI (IV).
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Table. VII Induction assay on the strain with the malX controlled helicase operon. Strain



















1.38±0.49 3.15±0.24 2.89±0.08 2.79±0.36 2.55±0.18 2.99±0.61 18.79±2.05
a. Data are the means ± standard deviations from three independent experiments.
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Fig. 18. Strategy to randomly insert the reporter gene lacZ into the chromosome of strain
SP1460. Chromosomal DNA was cut into pieces with MboI before it was ligated with
pEVP3 (BamHI). The recombined plasmids were amplified before they were used to
transform SP1460, in which helicase operon was under the control of PmalX. Each
transformant would have reporter gene lacZ inserted into one locus in chromosome of
SP1460. All the transformants were then replicate-plated on CATPG and CATPM
respectively.
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To determine the effect of the helicase operon on pneumococcal survival after
exposure to hydrogen peroxide, strains SP1000, SP1519, Rx1 and SP1460 were grown in
CATP with 22 mM maltose prior to hydrogen peroxide susceptibility assays. As shown in
Table VIII, in static culture, comparing to Rx1 and SP1000, both SP1460 and SP1519
were 10-fold more sensitive to hydrogen peroxide. However, there were no significant
difference between SP1460 and SP1519, or SP1000 and Rx1.
Also in Table 3-6, when the cultures were aerated for 20 minute before assay,
each strain became at least 10-fold more sensitive than static culture.
Effect of various concentrations of hydrogen peroxide on the survival of
SP1000 and SP1519
To confirm the results obtained from hydrogen peroxide sensitivity assay, SP1519
pre-grown in 22 mM maltose was treated with 2 mM, 4 mM, 6 mM, 8 mM and 10 mM
hydrogen peroxide. As shown in Fig. 19, the lowest concentration to have a lethal effect
on SP1000 was between 2 mM and 4 mM while for SP1519, it was between 0 to 2 mM.
These results confirmed that an active helicase operon made pneumococcal cells more
sensitive to hydrogen peroxide.
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Effect of the active helicase operon on the survival of pneumococcus
following treatment with other oxidative reagents
Results from hydrogen peroxide sensitivity assays show that induction of the
helicase operon makes pneumococcal cell more sensitive to hydrogen peroxide. This
result suggests two other possible oxidative inhibitors superoxide dismutase (sodA) [98]
and pyruvate oxidase (spxB) [15]. If it is true that the helicase operon down-regulates
expression of sodA, a strain with an active helicase operon should also be sensitive to
other oxidase reagents. To determine the effect of the helicase operon on survival of
pneumococcus in the presence of other oxidative agents, SP1519 were pre-grown in 22
mM maltose, and treated with methyl viologen or tert-butyl hydroperoxide respecitvely.
As shown in Table IX, after treatment with either methyl viologen or tert-butyl
hydroperoxide, there were no significant difference in survival rate between SP1000 and
SP1519.
Effect of the helicase operon on transcription of pyruvate oxidase
Since the possibility that the helicase operon would affect the expression of sodA
was ruled out, we wanted to determine if the helicase operon has an effect on the
expression of spxB.
97
LacZ transcriptional fusion to pyruvate oxidase
To create transcriptional fusion of lacZ to the gene encoding pyruvate oxidase
(spxB), a fragment of DNA completely internal to spxB was amplified from chromosomal
DNA using primers VJ115 and VJ116. The PCR product was inserted into pEVP3
(SmalI) to create E. coli plasmid pZH54. The recombined plasmid was sequenced by
using the primers flanking the SmalI site, pEVP3-F and pEVP3-R, to confirm that the
transcriptional orientation of the inserted DNA was the same as lacZ in pEVP3. To create
SP1525 and SP1528, the intact plasmid pZH54 was used as donor DNA to transform
pneumococcal strains SP1403 and SP1519, and chlorenphenicol was used as selection.
Examination of insertion of lacZ in pyruvate oxidase
When SP1525 and SP1528 were sub-cultured in CATPG supplemented with
BSA, about 8 hours of prolonged lag phase was observed. This prolonged lag phase
disappeared when sodium acetate was supplemented in the medium. When SP1525 and
SP1528 were spread on the surface of CATPG agar, their growth on the agar surface did
not require the presence of pre-added catalase. All of these characteristies perfectly met
the previously described characteristics of spxB mutant pneumococcus[14].
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TABLE.VIII. Effect of the helicase operon on the survival of pneumococci in hydrogen
peroxide.
Growth condition prior
to H2O2 exposure* Rx1 SP1000 SP1460 SP1519
Static 9.1 ± 6.07 14.7 ± 4.24 1.1 ± 0.78 1.88 ± 0.78
Aeration for 20 min. 0.06 ± 0.01 0.07 ± 0.05 0.012 ±
0.02
0.025 ± 0.01
* The cells were grown in 22 mM maltose to mid-exponential phase and divided into two
aliquots. One continued to be grown under static conditions. The other was grown
shaking at 200 rpm for 20 minutes at 37oC following which both were exposed to 10 mM
H2O2 for 30 minutes at 37
oC under static conditions prior to plating on agar plates to
select for survivors. The data given is an average of survival rates ± standard deviation of
three independent assays.
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Table IX. Effect of the helicase operon on pneumococcal survival in oxidative stress
methyl viologen tert-butyl hydroperoxide
SP1000 30.35%±5.16 42.90%±3.39
SP1519 37.30%±0.28 47.20%±6.50
Cells were grown in 22 mM maltose to mid-exponential phase and divided into two
aliquots. They were exposed to either 30 mM methyl viologen or 40mM tert-butyl
hydroperoxide for 30 minutes at 37oC under static conditions prior to plating on agar
plates to select for survivors. The data given is an average of survival rate± standard
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Fig. 19. Death curve of pneumococcus in a series of concentrations of hydrogen
peroxide. Hydrogen peroxide susceptibility assays were carried out separately using
strains SP1000 and SP1519 in the concentrations of hydrogen peroxide listed in figure.
The error bar represent the standard deviation of results from two independent
experiments.
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Effect of the helicase operon on the transcription of pyruvate oxidase in static
and aerated culture
To determine the effect of the helicase operon on transcription of spxB, SP1525
and SP1528 were grown in 22 mM maltose before β-galactosidase assay. As shown in
Table XI, after aeration, there was about a 70% increase in the transcription level of spxB
in both strains. By comparing SP1525 and SP1528, it was shown that the helicase operon
led to about a 30% increase in transcription of spxB in static culture. A similar level of
increase was also observed in culture after aeration.
Effect of the helicase operon on hydrogen peroxide production
It has been reported that up-regulation of spxB would lead to more production of
hydrogen peroxide. Since we figured out that inducing the helicase operon leads to
increased transcription of spxB [15], we wanted to determine if the production of
hydrogen peroxide is increased accordingly.
Making a Standard Curve for Hydrogen Peroxide Production Assay
To make standard curve, a hydrogen peroxide stock solution was diluted in CAT
to a series of concentrations. By using these samples in an assay, a standard curve was
generated. As shown in Fig. 20, the formula for the curve was y = 0.39x - 0.1327 with R2
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= 0.9993, in which the Y-axis represents the absorbance at 560nm and the X-axis for
hydrogen peroxide concentration in mM.
Effect of the helicase operon on hydrogen peroxide production in static vs
aerated cultures
Pneumococcal strain SP1519 was grown in CATP with 22 mM maltose before
cells were processed and used in assays. As is shown Table X, it was observed that cells
after aeration produced about 10-fold more hydrogen peroxide than static cultures.
However by comparing SP1000 and SP1519, neither in static culture nor in aerated
culture, was there a significant difference observed in hydrogen peroxide production
between SP1519 and SP1000.
Effect of the helicase operon on natural autolysis of
pneumococcus
Besides the effect on expression of spxB, we wondered if the helicase operon had
any effect on the other pneumococcal phenotypes. To determine the effect of the helicase
operon on natural autolysis, SP1519 was grown in CATPM. Time point 0 was set when
OD550nm of the culture reached 0.4. At this time, the culture was diluted and plated out for
viable count. Then at 3 hours, 5 hours and 8 hours, samples were obtained and plated for
viable counts. As shown in Fig 21, by comparing viable counts, there was no significant
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difference observed at 3 and 5 hours between SP1000 and SP1519. However, at 8 hours
SP1000 showed more than 4 times of surviving cells as compared to SP1519.
Effect of carbohydrate on pneumococcal survival in hydrogen
peroxide
It has been reported that pneumococcus is able to metabolize more than 20 types
of carbohydrates. In our study of the on helicase operon, we used maltose as an inducer to
activate the helicase operon. During the hydrogen peroxide sensitivity testing, we
happened to figure out that by comparing with glucose and maltose, lactose is able to
give pneumococcus an exceptional higher resistance to hydrogen peroxide.
To determine the effect of carbohydrate on survival of pneumococcus in hydrogen
peroxide, pneumococcal strain DP1004 was grown in CATP with 1% (w/v) various
carbohydrates, before the hydrogen peroxide susceptibility assay was performed. As is
shown is Table XII, all carbohydrates tried resulted in a similar survival rate after
exposure to hydrogen peroxide, except that lactose resulted in about a 10 fold higher
survival rate.
To determine if lactose, utilized in medium, was itself able to quench or detoxify
hydrogen peroxide, DP1004, was pre-grown in lactose, and resuspended in CATPG
before exposure to hydrogen peroxide. As is shown in Table XIII, pneumococcus
cultures, pre-grown in glucose, no matter which carbohydrate was used to resuspend cells
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before assay, resulted in a similar lower survival rate. Pneumococcus cultures pre-grown
in lactose resulted in a similar higher survival rate.
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Fig. 20. Standard curve for measurement of hydrogen peroxide production. Hydrogen
peroxide samples of known concentrations were used to obtaine a standard curve. In the
formula, y denotes for OD560, while x indicates for hydrogen peroxide concentration.
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(mM/hr/ 108 cfua) 
Static culture Aerated culture
SP1000 0.186 ± 0.020 2.034 ± 0.038
SP1519 0.199 ± 0.023 2.016 ± 0.064
a. The cells were grown in CATP with 22 mM maltose to mid-exponential phase before
assay. The data given is an average ± standard deviation of three independent assays.
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Table XI. Effect of the helicase operon on transcription of the gene encoding pyruvate
oxidase (spxB). The cells grown in 22 mM maltose or sucrose to mid-exponential phase
were divided into two aliquots. One continued to be grown under static conditions. The
other was grown shaking at 200 rpm for 20 minutes at 37oC, following which both were








SP1525 Static Sucrose 125.2±6.51
SP1525 Static Maltose 134.3±9.07
SP1525 Aerated Maltose 237.3±12.12
SP1528 Static Sucrose 139.4±6.68
SP1528 Static Maltose 186.4±4.2
SP1528 Aerated Maltose 301.7±11.71
a. The cells were grown in 22 mM of the indicated sugar. When needed, the cells
were aerated by shaking for 60 minutes at 37oC.



















Fig. 21. Effect of the helicase operon on natural autolysis of pneumococcus. Strains
SP1000 and SP1519 were grown in CATP with 22 mM maltose before assay. Survival
rate was calculated by the viable count obtained at each time point divided by the viable
count obtained at time point 0. The error bar represented the standard deviation of results
from three independent experiments.
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Table XII. Effect of carbohydrate on the survival of pneumococcus in hydrogen
peroxide. Strain DP1004 was grown to mid log phase in CATP with 1% (w/v)
carbohydrate as listed below before hydrogen peroxide sensitivity assay.









a. The cells were grown in 1% (w/v) of the indicated carbohydrate.
b. The data given are averages ± standard deviation derived from at least two
independent assays.
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Table XIII. Effect of lactose on survival of pneumococcus in hydrogen peroxide. Strain
DP1004 was grown in CATP with 1% (w/v) carbohydrate listed below, and then pelletted
and resuspended in CATP with 1% (w/v) carbohydrate listed below before hydrogen
peroxide sensitivity assay.















To date, a variety of conjugative transposons have been discovered and identified
among a range of bacterial species. Though there is no commonly accepted explanation
on the origin of this class of mobile elements, it has become evident that these elements
promote horizontal gene transfer among different species, even between different
families of bacteria. Besides the genes encoding the transposition machinery, very often
these transposons elements carry genes which are not involved in transposition but often
render a certain kind of selective advantage to their host. These genes help to establish a
synergitic relationship between the conjugative transposon and host cell, in such a way
that they may provide the host cell some type of survival advantage in a specific
environment, and this may enable the host cells to out-compete other cells from the same
species or different species in a given niche. When host cells gain success, conjugative
transposons may be maintained stably in that population.
The first conjugative transposon discovered was associated with the transfer of
multiple antibiotic resistance. This discovery, at that time, perfectly explained the
emergence and wide distribution of antibiotic resistance in several groups of Gram-
positive bacteria. Since then, by tracing the transfer of antibiotic resistance, many
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conjugative transposons have been discovered. In recent years, with the completion of
genomic sequences from a number of bacterial species, we are identifying a number of
conjugative transposons that do not carry any antibiotic resistance genes. This discovery
implies that all the known conjugative transposons carrying drug resistance may
represent only a small portion of a much larger number of such elements. It also implies
that there might be many other types of selective advantages besides antibiotic resistance
that such elements may carry and disseminate in the environment. Study of these
transposons has already revealed the functions of some of these genes. For example, in
Enterobacteria, conjugative transposons have been connected with pathogenicity islands
which render host species an enhanced ability to produce invasive infections [68]. Also,
there have been conjugative transposons identified from soil bacteria in which there are
huge operons responsible for the degradation of organic waste in the environment [99].
At the same time, there are still a number of genes residing in conjugative transposons
without any known function or biological significance. It is reasonable to believe that
some of these genes may have important functions other than antibiotic resistance.
In Tn5252, which our lab has been studying for some time, the region carrying
chloramphenicol resistance (cat) is flanked by direct repeats of an IS-like sequence. Due
to homologous recombination between the IS-sequence flanking the cat, cat cannot be
stably maintained in the absence of selective pressure. This implies that chloramphenicol
resistance may not be the most important advantage that pneumococcus acquires from
Tn5252 and there must be other genes that are critical to host cell in the element. The
genomic sequence of several bacteria species gives us a powerful tool to further analyze
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the non-transfer related regions in Tn5252. Almost perfect alignment of the DNA
sequence between coordinates 22.5 and 29.9 in Tn5252 with DNA sequences of
transposons in G54, S. suis 89/1591, S. agalactiae NEM316, and Streptococcus
agalactiae 2603V/R helped us to narrow our focus on a 7.4 kb operon containing 4 open
reading frames. The major part of this operon, ORF 2, was observed to encode a large
protein belonging to the DEAH* family.
Since the 7.4 kb helicase operon in the central region of Tn5252 was also
observed in other streptococcal pathogens, we hypothesized that this operon encodes a
virulence factor that may enhance pneumococcal virulence during infection. To study the
role of the helicase operon during infection, we attempted to introduce the operon from
the non-encapsulated laboratory strains into an encapsulated clinical strain by
conjugation. Initially filter mating was carried out by filtering cells through a 0.45 µm
filter. However, the extra-cellular polysaccharide outside the cell of the clinical strain
completely blocked the filter and prevented the solution from passing through. Since
filter mating between wild type clinical strains as recipients and laboratory strains
carrying the element was not successful, strategies other than filter mating were explored.
We hypothesized that the IS-like sequence in Tn5252 also could exist in the chromosome
of clinical strains. This hypothesis was supported by results obtained from the Southern
hybridization in which SP3001 and SP3101 showed hybridization to probe pSS141. It
was most likely due to the homology between an IS-like sequence in the chromosome of
the clinical strain with an IS-like sequence in pSS141. The band pattern representing the
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helicase operon was not seen in either SP3001 or SP3101, indicating that the operon was
not present in both the “wild type” clinical strains, D39 and WU2.
Though the helicase operon was inserted into the clinical strains by
transformation through the mechanism of insertion duplication, it was very unlikely that
any gene in the chromosomal DNA of the clinical strains was interrupted due to this
event. However, to prevent other complications during insertion of the helicase operon,
and to confirm that the differences in capability of infection are solely determined by the
helicase operon, we also created strains SP3005 and SP3103 in which the helicase operon
was mutated by insertion of cassette carrying an antibiotic resistance determinant.
It has been reported that the colony morphology of a clinical pneumococcal strain
determines its capability for infection [91]. Hence, the colony morphology of each strain
was examined. All the strains showed “transparent” morphology, based on criteria
described previously[91]. Also, it has been reported that phase variation happens with a
frequency of 10-5 to 10-7. Thus, the possibility that different colony morphology exists in
the strains used in the virulence assays can be ruled out.
Results obtained from the virulence assays indicated that the helicase operon
would decrease pneumococcal virulence during intraperitoneal challenge, while
increasing virulence during intranasal challenge. Though SP3004 cells were able to cause
significantly more or less death of mice than SP3001 or SP3005 in intranasal infection
and intraperitoneal infection, respectively, in either case, survival rate of mice obtained
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from SP3001 was not significantly different from strain SP3005. Similar results were also
observed with SP3101 and SP3103. This result helped to rule out the possibility that
insertion of the helicase operon into the clinical strains affected any virulence-related
gene(s) in the host cell DNA. It also confirmed that it was the helicase operon that was
responsible for the difference in infection. It also implied that the helicase operon was
active in both types of infection, since in each group the, “wild type” with the operon
showed a significant differently survival rate compared to “wild type” cells and “wild
type” cells with the mutated operon.
If the helicase operon is able to render some advantage or disadvantage during
pneumococcal infection as indicated in virulence assays, in a mixed infection with two
strains, the strain with the helicase operon should outgrow the “wild type” during
intranasal infection, or would be outcompeted by the “wild type” during intraperitoneal
infection. For this reason, competition experiments were performed to infect mice with
mixed pairs of strains, SP3003 and SP3004. Since it has been reported that clinical strains
with different chromosomal markers could result in a different capability to survival in
host, SP3001 and SP3003 were mixed and used for infection as a control. Consistent with
a previous report, SP3001 (str) outnumbered SP3003 (nov) during the nasopharyngeal
infection. Above that, SP3004 showed about 5 times better survival over SP3001 in the
nasopharyngeal region. On the other hand, SP3001 was outnumbered by SP3003 during
intraperitoneal infection. Above that, SP3004 was at least 4 times worse than SP3001 in
surviving during intraperitoneal infection. Consistent with this, similar results were also
obtained with WU2 derivatives. All of these confirmed the conclusion we drew in the
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virulence assay. Sequence analysis based on deduced amino acid sequences suggested
cytoplasmic localization of the proteins deduced by ORF1, 2 and 3. Results from
competition experiment also implied that the function of the helicase was probably within
the cell since a secreted factor would be expected to help both strains during mixed
infection and would not lead to a significant difference in their capability of survive in
the host.
Though there was evidence that the helicase was active during infection, by
inserting a reporter gene into ORF2, the lacZ fusion experiments showed that it was not
active when grown under laboratory conditions. To further determine the conditions
required for the induction of helicase operon, SP1472 was plated out with X-gal in a
chemically defined medium with various supplements. At least 5μmol Fe2+ was required
for induction of the helicase operon; however, no significant induction was observed in
the chemically defined medium broth with sufficient Fe2+ supplemented. This was
probably because the fact that Fe2+ is only one of several factors required for induction.
Without the presence of other required factors, there would not be full induction.
Based on the plating results, we conclude that Fe2+ is required for the induction of
the helicase operon. Sequence analyses predicted a metal binding motif and helix-turn-
helix motif was predicted in ORF1. We hypothesize that the protein encoded by ORF1 is
involved in the regulation of the helicase operon expression. To test this hypothesis,
SP1516 and SP1517 were created and plated out on a chemically defined medium with
X-gal and Fe2+ supplemented; both strains gave a light blue color after 72 hours. This
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result ruled out the possibility that ORF1 was the positive regulator required for
expression of the helicase operon since there was successful induction without ORF1.
Also, this result ruled out the possibility that ORF1 functioned as a negative regulator,
since SP1516 did not show any increased induction compared to SP1517. Taken together,
these results make it very unlikely that ORF1 is involved in regulation of the helicase
operon expression.
Though Fe2+ seemed to weakly induce the helicase operon, the conditions for full
induction of the operon remained unknown. However, to study its function, we inserted
an inducible promoter in between ORF1 and the natural promoter of the helicase operon
so that the operon could be induced. Insertion of the PmalX promoter, which would be
induced by maltose supplemented in medium, was achieved by cross-over PCR followed
by transformation of DNA into pneumococcus. The newly created strain, SP1460, was
analyzed by Southern hybridization to confirm that the construct in the promoter region
was as expected. Also, by insertion of a reporter gene into ORF2, it was confirmed that
the helicase operon could be induced by maltose as expected. At the same time, some
leaky expression in the presence of glucose was also observed.
Our attempts to identify all the genes influenced by the induction of the helicase
operon were not quite successful. One possible reason was that the leaky expression of
PmalX in the presence of glucose interfered in the screening procedure employed. Also it is
possible that our method for random insertion of a reporter gene into the chromosomal
DNA did not guarantee insertion into every possible gene in the chromosome.
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Our results indicated that induction of the helicase operon required at least 5
μmol of Fe2+ which has been reported to react with hydrogen peroxide in the Fenton
reaction and generate hydroxyl radicals, the active agent causing damage to cells[98]. As
previously reported, pneumococcus generate hydrogen peroxide as a metabolic by-
product during aerobic growth[14]. These observations led us to wonder whether the
helicase operon affected pneumococcal sensitivity to hydrogen peroxide. Our results
indicated that the helicase operon made pneumococcus cells more sensitive to hydrogen
peroxide which seemed to imply two possible targets of the helicase operon: superoxide
dismutase (sodA)[98], which would detoxify hydroxyl radicals generated during the
Fenton reaction; and pyruvate oxidase (spxB)[15] which would catalyze a reaction to
generate hydrogen peroxide. The first possibility could be ruled out since pneumococcus
did not show increased sensitivity to the other oxidative agents, such as methyl viologen
and tert-butyl hydroperoxide which produce superoxide anions. The superoxide anions
are known to be scavenged by superoxide dismutases[98].
A previously reported model to explain pneumococcal sensitivity to hydrogen
peroxide was that the ATP level in cells determines the sensitivity to hydrogen
peroxide[15]. Increased activity of pyruvate oxidase would in turn lead to more ATP
production and more hydrogen peroxide production which would lead to more resistance
to exogenous hydrogen peroxide. Results we obtained did not quite fit with this model. In
our system, when the expression of the helicase operon was induced, we observed
increased transcription of spxB with increased sensitivity to hydrogen peroxide. However,
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no significant change in hydrogen peroxide production was observed. One possible
explanation would be that when the helicase operon was induced, expression of genes
other than pyruvate oxidase were also affected, which led to more consumption of ATP
and hence more sensitivity to hydrogen peroxide. It is also possible that sensitivity to
hydrogen peroxide is much more complicated than determined solely by ATP levels and
that some other factors may play an important role in this process.
It is possible that the helicase operon increases virulence of pneumococcus during
intranasal infection by directly up-regulating or enhancing the expression of specific
virulence factors. However, this does not explain why the virulence of pneumococcus
during intrperitoneal infection was attenuated. From our results, we infer that when the
expression of the helicase operon was induced, multiple phenotype changes take place.
This implies that there are systematic changes in gene expressions rather than a change in
a few specific genes.
Based on all these results, the following model is proposed to explain the
mechanism of how the helicase operon modulates the virulence of pneumococcus. As
shown in Fig 22, in pneumococcal cells, there exists a global regulator X which is
involved in regulation of phase changes between transparent variants and opaque
variants. During pneumococcal infection, unknown signals from the host during infection
are capable of influencing the expression of X to make a complete change between
transparent variants and opaque variants. While expression of the helicase operon only
slightly changes the expression of X, it always results in a slight phase shift toward
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transparent phase. During intranasal infection, the slight shift toward the transparent
phase will make cells “more transparent” which will lead to enhanced expression of a
series genes involved in colonization in the nasopharyngeal region. During
intraperitoneal infection, a slight shift toward the transparent phase will make cells “less
opaque” which will lead to slightly attenuated expression of a series of genes involved in
invasive infection. Consistent with this hypothesis, when grown under laboratory
conditions, the strain with an induced helicase operon showed an increase in the
transcription of gene spxB and enhanced autolysis both of which fit with characteristics
of a transparent variant.
As shown in Fig. 22, it was reported that compared to opaque variants, transparent
variants have increased expression in prsA (spr0844) which is involved in protein
maturation, decreased expression in elongation factor (spr2019) [47] and decreased
expression of pspA [100]. To further examine the hypothesis above, experiments can be
proposed to determine if there is an increase of expression of prsA and decreased
expression of elongation factor and pspA in strains with an induced helicase operon. Even
further, in an encapsulated background, experiments can be proposed to determine if
there is a decreased amount of capsule in strains with the induced helicase operon.
Phase variation is a strategy that pneumococcus have developed to adapt to
different environments in vivo. Though pneumococcus is able to cause infection in quite
different places, the nasopharyngeal region is the place it has to colonize first. Since




Fig. 22. Hypothesis to explain the mechanism of how the helicase operon influences the
virulence of pneumococcus. A. In the strain without the helicase operon B. In the strain
with an induced helicase operon
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opaque variants are more efficient in causing intraperitoneal infections, it is expected that
before further invasive infection, there must be a phenotypic change to make
pneumococcus cells adapt the environment change. Efforts to understand the details of
pneumococcus phase variation have not been successful so far, since this change happens
at quite a low frequency under laboratory conditions. If our hypothesis on the mechanism
of how the helicase operon modulates the virulence is proved to be correct, it will provide
an alternative way to tackle the problem of phase variation. Further work to identify the
targets of the helicase operon may help to uncover the machinery involved in regulation
of phase variation and gain more understanding on the pathogenesis of pneumococcus.
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